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ABSTRACT 
Investigation of the cascade of events that leads to brain formation during 
embryogenesis allows an understanding of the processes involved that may well be 
applicable to future neurodegenerative therapies. Two genes at work during 
embryonic neurogenesis in a brain region called the superior colliculus are Sci, a 
member of the basic helix-loop-helix factor transcription factor family and Pax7, a 
paired box transcription factor containing a homeobox dornain. The superior 
coiliculus forms part of the visual system in mammals and in sepmate studies both the 
Sci and Pax? genes have been shown to be present in this fegion of the mouse brain 
from early neurogenesis onwards continuing into adulthood. This study was 
undertaken to ascertain whether both genes were operating within the same cells 
suggesting that they may be part of the same cascade of gene regulat()ry events during 
development or co-function in cells of the mature superior colliculus. Mice were 
analysed at seven different timepoints from embryonic day (E) 12.5, El5.5, El8.5 to 
the day of birth, postnatal day (P) 5, at weaning (P21) and in the adult brain. Their 
dissected brains were cryosectioncd and processed for (immuno)histochemistry. 
Preliminary results were generated with LacZ stainin!T to detect Sci expression and 
immunoperoxidase staining to detect Pax7. Confocal microscopy of 
(immune )fluorescent stained sections confirmed co-expression. 
Interestingly, expression of the Sc1 and Paxl transcription factors was found to 
overlap in a large subset of Pax? and Sci positive cells in the superficial layers of the 
mature superior colliculus and co-localisation in these cells was confirmed. By 
contrast, Paxl and Sci did not co-localise in these cells during embryonic 
neurogenesis. Compared with a range of neurogenic transcription factors that are 
down-regulated after embryonic neurogenesis, the continued expression of Scl and 
Paxl in the adult brain suggests a possible change in function from neuronal 
differentiation before birth to a possible concomitant maintenance of the cellular 
phenotype function in the adult brain. The lack of co-expression in the embry .mic 
brain does not support the hypothesis that Paxl and Sci are involved in the same 
developmental cascade of gene regulation. However, the finding that Pax? and Sci 
co-localise in mature neurons of the superior colliculus does allow for co-function of 
these two transcription factors. 
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1. INTRODUCTION 
7 
1.1 BACKGROUND TO THE STUDY 
The Stem Cell Leukaemia (Sci) gene encodes a basic helixMloop~hdix transcription 
factor that was originally identified through a translocation of the gene to the T -cell 
receptor locus in acute lymphoblastic leukaemia The gene is essential for the early 
development of the haematopoietic and vasculogenic system (B('gley and Gre~n. 
1999). Studies indicate that Sci functions as a cell fate determinant in the 
haematopoietic system by regulating the proliferation of multi potent haematopoietic 
stem cells (Green ct al., 1991; Elefanty et al., 1997), directing the differentiation of 
erythroid cells, megakaryocytes and mast cells (Green et al., 1991) and developing 
the yolk sac vessels (Robb et al., 1995). Sci expression has also been found in the 
central nervous system and the expression pattern of Sci in the b1·ain has been mapped 
using an Sci LacZ knockin reporter mouse. The expression mapping shows a high 
degree of expression in the dorsal superficial layers of the superior colliculus, the 
pretectal area, the tegmental regions and moderate to low density expression 
throughout the midbrain, hindbrain and caudal thalamus (van Eekelen et al., 2003). A 
recent Sci gene deletion study has indicated that. Sci is required for normal 
mid/hindbrain development, suggesting a cell fa1.e determinant role for Sci in 
neurogenesis (data to be submitted for publication by van Eekelen et al.). 
The Pax? transcription factor is encoded by a member of the paired box gene family 
first identified in Drosophila (Bopp et al., 1986). The expression pattern of the Pax7 
gene suggests a functional role in development of neural crest, skeletal muscle and 
the central nervous system (Mansouri et a!., 1996). Pax? appears to be a significant 
factor during brain development, functioning in regionalisation and polarity of the 
superior colliculus. Pax? has also been implicated with refining the optic nerve 
innervation to the dorsal layers in the superior colliculus dming early postnatal 
development (Thomas et al., 2004). The adult Pax7 expression pattern is similar to 
that of the late embryo with prominent expression found in the dorsal superficial 
layers of the superior colliculus (Stoykova and Gruss, 1994). 
The Sci and Pax7 genes display a high level of expression during embryonic 
neurogenesis particularly in the mesencephalon (midbrain) during the formation of 
the superior colliculus. Both factors continue to be expressed in the dorsal layers of 
the superior colliculus in postnatal and adult brain (Stoykova and Gruss, 1994; 
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Nomura et al., 1998; Matsunaga, 2001; van Eekelen et al., 2003; Thomas et al., 
2004). This spacio-temporal overlap in expression suggests that Sci and Pax7 may be 
invoived in related functions during brain development and in the adult brain. 
Expression of Sci and Pax7 throughout embryonic neurogenesis, implies a function in 
detennining cell fate andJor differentiation, particularly in the superior colliculus 
(Stoykova and Gruss, 1994; van Eekelen et al., 2003). In addition, with the 
expression of both factors in regional organisational centres of the developing brain, a 
regionalisation function is suggested (Kawakami et al., 1997; Matsunaga, 2001; van 
Eekelen et al., 2003) and continued expression in post-mitotic cells after birth also 
implies a role in the maintenance of the cellular phenotype of Sci and Pax7 
expressing neurons (Stoykova and Gruss, 1994; van Eekelen eta!., 2003). 
1.2 SIGNIFICANCE OF THE STUDY 
This study will help detennine more accurately the roles of Scl and Pax7 in neuronal 
function and contribute to the understanding of factors involved in embryonic and 
adult neurogenesis. This is essential for future development of possible therapies for 
neurodegenerative diseases based on the endogenous generation of new neurons in 
the adult brain, rather than by transplantation methods or gene therapy. 
1.3 HYPOTHESIS 
Pax7 and Scl co-localise within cells of the mesencephalon from embryonic 
neurogenesis to adulthood indicating a co-ordinated neurogenic function of both 
transcription factors in developing and mature neurons. 
1.4 AIM 
The aim of this study is to investigate the co-expression of the Sci and Pax7 genes as 
a basis for a common functional role of the two genes in embryonic, postnatal and 
adult brain. To do this a detailed morphological analysis of Pax7 and Scl co-
localisation in the brain at different stages of embryonic neurogenesis as well as after 
birth, at weaning and in the adult brain will be performed. This detailed analysis 
includes the generation of an accurate but so far not reported map on the expression 
pattern of Pax7 during embryonic neurogenesis and postnatal development. 
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2. LITERATURE REVIEW 
!0 
2.1 THE Sci GENE 
2.1.1. Sci is an oncogene in T-ce/1 Acute Lymphoblastic Leukaemia 
(F-ALL) 
The Sci gene, also referred to as Tcl-5 and Tal-l, was originally identified through a 
translocation from chromosome 1 into the T~cell receptor locus on chromosome 14. 
At the new locus, aberrant production of the transcription factor caused the gene to 
become oncogenic leading to T-ALL. Further, deit:t\ons at chromosome 1 have put 
the Sci g~ne under the control of the ubiquitous Sit promoter also resulting in T-ALL 
oncogenic function. The mechanism involved in transforming the cells into a 
leukemic state is unknown but Sci is thought to increase proliferation and decrease 
cell death (Begley and Green, 1999). 
2.1.2 Sci encodes a bHLH transcriptwn factor 
Basic .helix-Iovp-helix (hHLH) transcription factors play a major role during 
embryogenesis in determining neuronal subtype specification and differentiation 
(Guillemot et al., 1993). The bHLH structure contains two important binding domains 
with the basic domain facilitating DNA binding while the helix-loop-helix domain 
l:dnds other proteins to form heterodimers. Scl is a class B HLH protein known to 
bind with class A proteins such as E2A, that acts as a transcriptional activator, to 
form a heterodimer that binds DNA at the E-box of downstream gene enhancers, 
regulating developmental pathways (Hsu et al., 1991). Sci binds to CAGGTG E-
boxes with a higher binding affinity if the E-box is followed by a GATA motif or 
with a lower binding affinity if an upstream CAGATG E-box is nearby (Cohen-
Kaminsky et al., 1998). The HLH domain can bind with other proteins to form a 
larger protein complex. The individual proteins involved in complexes may have no 
singular effect on downstream target genes but may all be necessary compm:ents in 
order to activate the synergistic complex in an all or nothing manner (Lecuyer and 
Hoang, 2004) . The specific protein interactions allow for a precise spacio-temporal 
activation of the target gene. Specific complexes will differentially activate each 
target gene. A protein change within a multifactorial complex may make for a more 
efficient activator to certain downstream genes (Lecuyer and Hoang, 2004). There are 
a number of Sci isoforms that may well vary the activational function of a complex 
and create diversity between cell types, regions and stages of differentiation. (Begley 
and Green, 1999; Calkhoven eta!., 2002). 
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2.1. 3. Characterisation of enhancer sequences in the Sci gene 
The Sci gene is expressed in the haematopoietic system, endothelial cells and the 
brain and specific enhancers within the Sci locus have been identified to direct Sci 
expression specifically to these functionally different cell types. A 3' Sci enhancer 
has been described that targets the haemangioblast, a precursor for both 
haematopoietic stem cells and endothelial cells (Gottgens et al., 2002) and a 5' 
endothelial enhancer has also been demonstrated. Of concern to this project is the 5' 
Sci neural enhancer (940bp) used in the construct of a transgenic mouse model that 
directs transgene expression under this regulatory gene sequence stretching from 
-0.9kb to Exon 3 (0.9E3). This enhancer is important for Sci expression within the 
midbrain, hindbrain and spinal cord. Exon Ia forms part of the promoter and is 
essential for directing expression to the midbrain (Sinclair et al., 1999). 
2. 1. 4. The function of Sci in haematopoiesis 
Early research an Sci has shown that the Sci gene is essential for the early 
development cf the haematopoietic and vasculogenic systems (Begley and Green, 
1999). Functional studies of the haematopoietic system have found Sci expressed in 
primitive haematopoictic stem cells, progenitor cells and differentiated erythrocytes, 
megakaryocytes and mast cells (Hall et al., 2003). Sci regulates multi-potent 
haematopoietic cell proliferation, facilitates erythroid differentiation and inhibits 
myeloid differentiation (Kallianpur, 1994; Begley and Green, 1999). A conserved 
upstream open reading frame acts as a trm~s!ational control mechanism regulating 
differing Sci isoforms. The isoforms vary in the translation of theN terminus while 
all retain the bHLH domain. Specific Sci isoforms determine lineage commitment 
with the truncated Sci isoform promoting the erythroid lineage while the full length 
Sci protein follows the megakaryocyte lineage (Calkhoven et al., 2002). Evidence 
that Sci is a critical factor within haematopoiesis is displayed in the knockout model 
by the failure of embryos to survive beyond E9.5 with death occurring from hypoxia 
following on from absolute anaemia and yolk sac failure (Robb et al., 1995) at the 
stage when foetal circulation is meant to conunence. While embryonic blood vessels 
develop typically in the knockout model, vessels within the yolk sac display no 
patterning and fail to develop without Sci (E:efanty et al., 1997). To functionally 
assess Sci in the adult haematopoietic system, conditional Sci-null mice based on the 
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Mx-Cre/ioxP system have been developed that knock out the Sci gene upon interferon 
administration at a chosen timepoint. These studies have shown that Sci has a 
function in adult haematopoiesis by maintaining megakaryocyte production and 
erythropoiesis. Macrophages, granulocytes and myeloid progenitors are unaffected by 
the Sci deficiency even though Scl expression is found within the myeloid progenitor 
(Hallet a!., 2003). 
2.1.5. The function of Sci in the CNS 
Sci expression in the central nervous system has been mapped using a Scl LacZ 
knockin reporter mouse (van Eekelen et al., 2003). Sci is expressed in regions of the 
foetal brain known to differentiate into the Scl expression domains of the adult brain. 
Expression is found in the diencephalon (caudal thalamus of the forebrain), the 
mesencephalon (midbrain) including the superior colliculus and substantia nigra and 
in metencephalon (hindbrain) (van Eekelen et al., 2003). Sci does not express in glial 
cells but it does in post-mitotic neurons. In general, Scl expressing cells are found 
evenly scattered over different brain regions suggesting that only a percentage of cdls 
express Sci (van Eekelen et al., 2003). Embryonic Sci expression surrounds the 
aqueduct in the intermediate and marginal zone of the neuroepithelium and the fourth 
ventricle in the ventricular zone suggesting an involvement in the differentiation and 
possible neuronal subtype specification of migrating neurons from neural stem cells 
during development (van Eekelen et al., 2003). 
The most prevalent Sci staining in the adult brain is seen in the superior colliculus 
with a decreasing expression gradient observed over the seven layers from dorsal to 
ventral. There is a high density of LacZ staining in the dorsal zonal and superficial 
grey layers of the superior colliculus, a moderate density in the optic layer and a low 
density jn the intermediate and deep layers. Low density Sci expression is seen in the 
cortex of the inferior colliculus (van Eekelen et al., 2003). Scl expression in the 
superior colliculus particularly implies a potential role in the oculomotor, pupillary 
and retinotectal visual pathway. Functional studies on the role of Sci in the central 
nervous system are currentlY being undertaken using conditional gene knockout 
mouse models that knockout the gene within the brain only. Preliminary results show 
that the spatial Scl knockout in the brain results in a runted animal with 25% of 
animals dying at birth and a further 35% at weaning age and are growth retarded. The 
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remaining animals display hyperactive behaviour. Furthermore, a subset of neurons 
that express Sci in the normal brain are absent in the mid and hindbrain of the 
condition~! knockout and suggest a crucial role for Sci during brain development. 
(Personal communication from JAM van Eekelen at the Telethon Institute for Child 
Health Research). 
2.2 TRANSGENIC MOUSE MODELS 
In order to make functional hypotheses for specific genes, researchers have been 
manipulating the pluripotent embryonic stem cells of mice to make gene knockout 
mouse models by homologous recombination. A phenotypic analysis of loss of 
function may be made by replacing the gene sequence with an alternative construct, 
deleting the gene from the genome or knocking in a different gene, to give an 
indication of function (Garcia and Mills, 2002). The complete removal of some genes 
from the genome results in a lack of offspring because the gene concerned is 
necessary for the development and survival of the anima!. Such is the case for the Sci 
gene, which is imperative to the development of the haematopoietic system rendering 
an ombryo unviable beyond E9.5 (Robb et al., 1995). By using the full Sci knockout 
model it is impossible to study Sci function in the brain. Conditional gene models 
have been designed to circumvent the problems of lethality during embryogenesis 
allowing genes to be deleted in both a spatial and temporal manner (Garcia and Mills, 
2002). 
2. 2.1 The CrelloxP System 
Cre recombinase (Cre) is an enzyme produced in the bacteriophage PI that 
recombines DNA at specific recognition sites called loxP sites. ThP. loxP sites have 
two 13bp inverted repeat regions that bind Cre and a central 8bp spacer where 
cleavage and recombination occur. When bound by Cre, L"le DNA between two loxP 
sites is cleaved (Sternberg and Hamilton, 1981). Genetically manipulated mice are 
inter-crossed to produce offspring that carry two loxP sites on either side of a 
pertinent area of the gene in quedtion (flexed) and also carry the Cre sequence within 
its genome. When Cre is expressed it will recombine the loxP sites by cleaving the 
gene sequence in between (Fig. 2-1.) (Garcia and Mills, 2002). 
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LoxP site LoxP site 
~------~:::~ ;> bHLH ~----------~ 
+ @ 
Recombination Cleaved Scl sequence 
Figure 2-1. The conditional Sci knockout mouse. Cre recombinase, produced under the neural-specific Nestin 
promoter, will bind two LoxP s ites, cleave and circularise the DNA in between and recombine the original strand. 
The previously mentioned conditional Sci knockout model has been generated such 
that, Cre expression is regulated by the promoter and neural tissue-specific enhancer 
of the proneural gene, Nestin (Tronche et al., 1999). LoxP sites have been inserted 
into Sci flanking the region encoding the bHLH domain (Fig. 2. 1 ). Cleaving of the 
gene is spatially restricted to the brain because Cre is only expressed in the neural 
progenitor cells. 
2. 2. 2. Reporter genes 
In most cases where knockout models have been generated, the gene of interest has 
been replaced by a knockin gene being a reporter gene placed under the control of the 
regulatory sequences of the gene of interest. This has been done for Scl and has 
provided an excellent Scl-LacZ knockin reporter mouse to study the expression 
pattern of Sci in the brain. The LacZ reporter gene has been knocked-in to the Sci 
locus (Fig. 2.2) in the region encoding the translational sequence of the Scl gene and 
is expressed under the Scl endogenous promoter in all Scl expressing cells. 
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LacZ Kl 
1a 1b 2 3 4 5 6 ex on 
Figure 2.2: The LacZ reporter gene is knocked into the Sc/ locus at the bHLH site and expressed under the 
SCL promoter. 
The LacZ reporter mouse is extremely useful for gene expression studies within the 
brain because the Sci monoclonal antibodies that can be used for Western blotting are 
ineffective in the immunohistochemical studies on brain sections. Once the f)-
galactosidase enzyme assay has been completed on tissue sections, a blue reaction is 
visualised (Hatton and Lin, 1992) where Sci is normally expressed. To avoid creation 
of a knockout mouse, heterozygous mice are used, which express the LacZ reporter 
gene from one allele while the normal expression of Scl still occurs from the other. 
Unfortunately, the LacZ signal is not strong enough for immunofluorescent 
histochemistry using an antibody against the X-gal protein. As an alternative, a 
mouse model containing the enhanced Yellow fluorescent protein (eYfp) reporter has 
been developed. e Yfp is knocked-in to the Rosa26 locus, which is a housekeeping 
gene ubiquitously expressed and resulting in a high level of fluorescence (Srinivas et 
al., 2001 ). Moreover, a stop sequence flanked by LoxP sites precedes the reporter 
gene in this knockin mouse resulting in e Yfp expression only if the stop sequence is 
recombined/deleted by Cre (Fig. 2.3); (Srinivas et al., 2001 ). 
In the group supervised by Dr. van Eekelen at ICHR, aCre transgenic mouse has 
been generated in which Cre is expressed under the control of the 5' Sci neural 
enhancer (0.9E3) and . is produced only in Sci expressing neurons. Thus until the 
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expression of Cre no e Y fp will be produced in Sci-expressing neurons because of the 
presence of a stop sequence at the start of the e Yfp gene. However, upon Cre 
expression, the stop sequence is cleaved and eYfp is produced. 
CYTOPLASM 
NUCLEUS 
Cre-
ERT 
--0 
--------... ~~ 
Figure 2.3 Cre recombinase is expressed under the Sci neural enhancer and fused to an oestrogen receptor ligand-
binding domain. The protein is held within the cytoplasm by the heat shock protein 90. On the administration of 
tamoxifen, heat shock protein 90 is released, a conformational change is induced and Cre enters the nucleus where 
it c leaves the stop sequence and e Yfp is expressed under the ubiquitous GTRosa promoter. 
To add temporal control over deletion of the floxed gene of interest (R26R-EYfp in 
this study), the 0.9E3 Cre transgenic mouse was generated as an inducible Cre mouse 
with Cre fused to a mutated oestrogen receptor ligand-binding domain constructed to 
mimic the nuclear hormone receptor (Brocard et al., 1997). When the hormone binds 
to the receptor, the protein is translocated into the nucleus for DNA binding (Fig 2.3). 
Without hormonal binding the protein remains in the cytoplasm bound to heat shock 
protein 90. The introduced oestrogen receptor ligand-binding domain is mutated such 
that Cre can only be activated by tamoxifen (Fig. 2.3). The three mutations within the 
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receptor prevent the binding of endogenous oestrogen (Brocard et al., 1997). Taken 
together, eYfp expression in the brain will reflect Sci neural expression upon 
tamoxifen administration. 
The different models discussed are of relevance to this study as the Sci antibody is 
ineffective when immunostaining brain tissue. The Scl-LacZ knockin model has been 
designed as a reporter for Sci expression, displaying good morphology and suitable 
for light microscopy while the Brain-Cre x GTRosa26-e YJP model has been valuable 
for fluorescent and confocal microscopy. These conditional mouse models allow us to 
perform several experiments that enhance or further our understanding of the role of 
Sci in the CNS. 
2.3 THE Pax7 GENE 
2.3.1. Paxl is a :ranscriptionfactorwith a paired domain 
The Paxl gene encodes a transcription factor that contains a paired DNA binding 
domain first identified in the paired protein of Drosophila me lana gaster (Bopp et al., 
1986). The Pax7 gene is one of nine family members 1hat encode a DNA binding 
domain from a gene region called the paired box (Pax). The encoded paired domain 
forms six a-helices grouped into two helix-turn-helix motifs, is 128 amino acids long, 
and in close proximity to the amino terminus of the protein. In addition, Pax? 
contains a 61 amino acid paired type homeodomain (Jostes et al., 1990; Stoykova and 
Gruss, 1994) as well as a conserved octapeptide sequence (Fig 2.4). Pax proteins, like 
other transcription factors are thought to bind enhancer sequences of downstream 
genes with their DNA binding domains. 
The Pax proteins have been grouped into different classes according to their structural 
differences and Pax7 has been, classified as a Class II protein as it contains the paired 
box DNA binding domain, the full length homeodomain encoding region and the 
conserved octapeptide (Ziman et al., 2001 b). Pax? also contains a transactivation 
domain (Fig. 2.4) binding other proteins to induce downstream gene transcription 
(Ziman eta!., 200Ia). 
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domain 
Transactivation 
domain 
Figure 2.4 Pax7 protein schematic showing the subdomains of the paired domain, each 
containing a helix-turn-helix motif, an octapeptide, the helix-turn-helix homeodomain and the protein-
binding transactivation domain (Chi and Epstein, 2002). 
Another Class II protein homologous to Pax7 is Pax3, with a structure closely 
resembling that of Pax7 and thought to offer partial redundancy where the expression 
domains overlap (Mansouri et al. , 1996). The diversity in function of Pax7 throughout 
development is thought to be explained by the identification of different protein 
isoforms. Alternate splicing regions within the intron-exon boundaries of the Pax7 
paired box encode different proteins thought to operate in specific spatial and 
temporal domains. The alternate splicing within the paired box region may modify 
the proteins tertiary structure, thus altering DNA binding and activating different 
pathways (Ziman et al., 2000; Ziman et al., 2001 a). Further, six different PAX7 
allelic forms have heen identified. 
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2.3.2. Neural enhancers ofPax7 
The distinct expression patterns of Pax7 within the central nervous system are under 
the regulatory control of more than one enhancer. While the promoter region of Pax? 
is located -2.lkb upstream ofExonl, an enhancer region is positioned within the first 
intron of the gene regulating expression of Pax7 in the brain region, the pons. By 
contrast, Pax7 expression at the midbrain/hindbrain boundary and the cerebellar 
ventricular zone is regulated by elements -4kb upstream of the gene. An enhancer 
situated within the upstream -1 Okb of Pax? regulates the roof plate, cephalic neural 
crest and mesencephalic tecta! expression (Lang et a!., 2003). Within the upstream 
promoter region of Pax7, seven different E-boxes have been observed. At -2073 there 
is a CACCTG sequence, -1861 has a CAGGTG sequence, -1393 has a CATCTG 
sequence, -1051 has a CACGTG sequence and -956, -570 and -280 all have the 
CAGCTG E-box sequence (Personal communication Rob White, Centre for Human 
Genetics). TheE-box sequences located within the promoter region upstream of Pax7 
make an opportune site for other transcription factors such as Sci to binrl and induce 
Pax7 expression perhaps as part of a neurogenic pathway. 
2.3.3. The function of Pax7 in the musculo-skeletal system 
The expression pattern of Pax7 suggests that it has a ftmction in cephalic neural crest 
cells and the development of skeletal muscle as well as the central nervous system 
(Gruss and Walther, 1992). From E9, early dorso-ventral somite patterning is thought 
to be regulated by Pax7 and Pax3. Pax? expression is then restricted to the 
dennamyotome. Later it is observed in skeletal muscle progenitors (Kawakami et al., 
1997) and in the intercostal muscles (Jostes et al., 1990). A myogenic progenitor cell 
termed a satellite cell is found as a quiescent muscle precursor nonnally adjoining 
mature muscle fibres. Duriug muscle regeneration, satellite cells proliferate and fuse 
to form new muscle fibres. Persistent Pax7 expression maintains the precursors in an 
undifferentiated state, remaining expressed when cells are activated but disappearing 
on terminal differentiation. Satellite cells are ab::;ent in the Pax? knockout mice and a 
runted animal results, deficient in postnatal skeletal muscle growth (Seale et al., 
2000). 
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2.3.4. The junction ofPax7 in the CNS 
The Pax genes are implicated in a variety of functions based on temporal and spatial 
restriction of expression in the brain from early embryogenesis through to early 
postnatal development. Pax7 initially expresses in the neural tube at embryonic day 8 
along the dorso-ventral axis during neural tube development and before cellular 
differentiation (Jostes et al., 1990; Stoykova and Gruss, 1994; Nomura et al., 1998). 
Once the neural tube has closed, the neural epithelium becomes a mitoticaii:v active 
ventricular zone generating stem cells for the developing central nervous system. At 
this time, Pax 7 persists in the dorsal ventricular zone until the ventricular zone 
reduces reducing its mitotic activity (E14) (Jostes et al., 1990). Pax genes then 
display a role in regional differentiation of the embryonic brain by expressing within 
or between regions that correlate to anatomical borders (Stoykova and Gruss, 1994). 
Pax? and Pax3 are part of the cascade that delineates the midbrain from the forebrain 
(Stoykova and Gruss, 1994) while the homologues Pax2 and Pax5 are expressed at 
the midbrain/hindbrain boundary (Stoykova and Gruss, 1994; Bouchard eta!., 2000). 
From the delineation of anatomical borders, Pax? is then involved in establishing 
regionalisation and polarity of the superior colliculus (optic tectum). This has been 
demonstrated by the misexpression of Pax7 in the diencephalon inducing the 
formation of an ectopic tectum showing innervation and lamination by retinal axons 
(Matsunaga, 2001). During embryogenesis, Pax? expressing cells migrate from the 
ventricular zone to the stratum griseum superficiale, a region of the superior 
colliculus that later receives retinal ganglion cell input. This implies a later 
specification and/or differentiation role for Pax?. Pax? displays an expression 
gradient of rostral10w- caudal high and dorsalhigh- ventral10w within the tectum throughout 
development implying a role in the polarity of the superior colliculus (Thomas et al., 
2004). Co-expression of Pax? with ephrin-A2 during early postnatal development, 
suggests a role for Pax? in establishing the retinotectal m~p and refining optic nerve 
innervation. Pax? achieves this in part by regulating ephrin-A2 expression (Thomas et 
al., 2004). In the adult brain, Pax? expression is found along the rostra-caudal axis of 
the brain with particularly high expression levels within the dorsal superior colliculus 
similar to expression patterns in the embryonic brain (Stoykova and Gruss, 1994). 
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The Pax7 knockout mouse survives to term but usually dies prior to weaning while 
the heterozygous animal develops and reproduces normally. Phenotypically, the 
knockout exhibits severe growth retardation with a shortened maxilla, smaller serous 
gland tubules and a pointed snout. Derivatives from areas of overlapping temporal 
expression of Pax3/7 in the neural tube appear normal in the Pax7 knockout model. 
This suggests that the paralogue gene Pax3 has played a compensatory role for the 
loss of Pax7 (Mansouri et al., 1996). 
2.4 TRANSCRIPTION FACTORS AND BRAIN DEVELOPMENT 
In general, brain development i.e. neurogenesis and gliogenesis, relies on a cascade of 
events driven by changes in gene expression profiles of proliferating and 
differentiating neuroepithelial cells. These events are steered by transcription factors 
which themselves are developmentally regulated. The many known families of 
transcription factors involved in developmental processes each have their specific 
properties like the structure of the DNA binding domain e.g. the helix-loop-helix 
motif that determines the interaction at th"' DNA groove. Transcription factors may be 
activated by specific intracellular pathway signalling as a response to cell membrane 
receptors and extracellular signalling interactions. On the other hand, they may be 
dependent on the binding to other nuclear proteins to influence their activity. In turn 
however, all transcription factors alike bind to enhancer and promoter sequences of 
downstream genes in a pattern that results in the activation or repression of the genes. 
During early neurogenesis, the differences in patterning direct cells to become 
committed to the neuronal fate and specified to those cellular phenotypes required for 
a particular region. The best studied example of this occurs at the midbrain/hindbrain 
boundary after neural tube closure from E8.5 to E12.5. 
2. 4.1. The midbrain/hindbrain boundary development 
The area designated at the midbrain/hindbrain boundary is known as the isthmus. 
During neurogenesis, the isthmus is considered a mid-hindbrain organiser that forms 
at the junction of the expression domains of the transcription factors Otx2 and Gbx2 
(Fig. 2.5) (Broccoli et al., 1999; Joyner et al., 2000) and the anterior domain of Fgf8 
express~on (Shamim et al., 1999). Otx2 is found expressed in a decreasing gradient 
toward the isthmus from the midbrain while Gbx-2 is expressed in a decreasing 
gradient from the hindbrain (Joyner et al., 2000). In a developmental cascade Otx2 
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induces Pax2 that activates the expression of Enl, which enters a feedback loop with 
the signalling molecule Fg/8 that regulates the later expression of Pax5 (Liu and 
Joyner, 2001). Pax5 upregulates En2 with a positive feedback loop developing 
between the two genes. Enl and En2 expression overlaps that of Pax2 and Pax5 
across the isthmus (Joyner, 1996) and Enl, En2 and Pax5 expression is found 
throughout the mid/hindbrain boundary region (Liu and Joyner, 2001). The cascades 
ultimately result in the formation of the superior and inferior colliculi (as discussed in 
section 2.1. 14), posterior midbrain, cerebellum and possible ventral brainstem 
(Trokovic et al., 2003). 
Signalling molecules from one region have been demonstrated to repress the 
signalling molecules from the abutting region with the overlap found at the isthmus. 
The Otx2 and Gbx2 border is required to position the expression of the signalling 
molecules Wntl and Fg/8. Initially, W n t 1 and Fg/8 are found outside the 
mid/hindbrain boundary in the entire midbrain and rhombomere 1 of the hindbrain 
respectively but on neural tube closure, Wntl (posterior midbrain) and Fg/8 (anterior 
hindbrain) expression becomes restricted to adjacent narrow rings at the isthmus until 
embryonic day 12.5 (Liu and Joyner, 2001). 
Figure 2.5 
Expression patterns at the isthmus of embryonic mouse brain. After neural tube closure, the 
transcription factor Otx2 expresses in the presumptive midbrain and the signalling molecule Wntl is 
expressed in a narrow ring at the isthmus. The transcription factors Gbx2 and Pax2 express in the 
presumptive hindbrain with Pax2 abutting that of Wntl expression (Brown eta!., 2001). 
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The important elements involved at the mid/hindbrain boundary are associated with a 
regulatory feedback loop that maintains the expression of each other (Shamim et al., 
1999). Gradients of opposing and overlapping expression act by mutual repression to 
maintain each regional identity. This is also observed at the mid/forebrain boundary 
around the same period ofneurogenesis. 
2.4.2. The midbrain/forebrain boundary development 
Although the mid/forebrain boundary is not as well described as the mid/hindbrain 
boundary, it can serve as another example of how the specific expression patterns of 
transcription factors and their interplay influence brain development. The caudal 
forebrain is divided into three compartments being the pretectal region, the dorsal 
thalamus and the ventral thalamus. Between the midbrain and pretectrun lies the 
posterior commissure. On the induction of Pax7 in the midbrain there is a 
simultaneous suppression of Pax6 and Pax6 expression is found in the diencephalon 
abutting that of Pax7. The anterior boundary of the midbrain is defined by the rostral 
Pax7 and the caudal Pax6 expression found in the posterior commissure of the 
pretectum (Stoykova and Gruss, 1994). Expression patterns of Pax6 and Pax7 in the 
pretectum suggest that they are expressed in different cell populations (Kawakami et 
al., 1997; Nomura et al., 1998). The En genes are thought to be transcriptional 
repressors, and with a decreasing expression gradient across the midbrain from caudal 
high to rostral low, these factors are also thought to repress forebrain genes at the 
mid/forebrain boundary. Pax2 is also thought to repress Pax6 at the mid/forebrain 
bo~ndary (Stoykova and Gruss, 1994). Otx2 and Emx2 are factors suggested as 
having a developmental function in the forebrain although not in the posterior 
commissure (Suda et al., 2001). 
2.4.3. Development of the superior col/icu!us 
Patterning of th~ early midbrain then allows these committed and specified 
neuroepithelial cells to migrate to their final destination and take part in the 
organisational phase of specific brain region development. The basic fonnation of the 
superior colliculus from sin.·Jle neuroepithelium occurs primarily between Ell-El4. 
The mature superior colliculus is composed of seven layers with alternating layers of 
fibres and cells, while the formative superior colliculus consists of three primary 
layers, the stratum superficiale, the stratum intermedium and stratum profundwn 
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(Edwards et al., _986b). From Ell, cells generated in the ventricular zone of the 
.nesencephalic neuroepithelium, containing the germinal epithelial cells, migr?t~ 
dorsally to the intermediate and marginal zones. The superficial layer is formed after 
the deep layers but prior to the completion of the intermediate layer. Superficial and 
deep layers are formed from independent cell populations (Edwards et al., 1986b). 
Peak cell generation for the superficial layers of the superior colliculus occurs from 
E12 (strata opticum) to E13 (stratum griseum superficiale) while the deeper layers are 
formed at Ell-E13 (Edwards et al., 1986b). Lamination or the layering of neurons 
and fibres in the intermediate and deeper layers begins at E14. By E15, a few retinal 
ganglion cell projections have reached the superficial layers and by El? a large 
population of retinal ganglion cell axons penetrate all superficial layers concurrent 
with the near completion of cell migration (Edwards et al., 1986b). 
The lamination process continues until the late embryonic and early postnatal periods 
accompanied by a considerable radial growth. At birth there are dense fibre bundles 
through all superficial layers but for the first 6 postnatal days these are removed from 
the stratum griseum superficia/e (superficial grey layer) while those in the stratum 
opticum (optic layer) remain (Edwards et al., 1986b). Simultaneously, collaterals 
from axons in the stratum opticum extend and arborise the stratum griseum 
superficiale (Edwards et al., 1986a). The topography of retino-tectal projections has 
predominantly come from studies performed in chick (Matsunaga, 2001; Nakamura, 
2001; Thomas et al., 2004). Generally, axons from the temporal retina project to the 
contralateral anterior superior co11iculus while axons from the nasal retina project to 
the contralateral posterior superior colliculus (Bahr and Wizenmann, 1996). The 
topography of the tectum (the homologue to the superior colliculus in lower 
vertebrates) is thought to be formed from signalling molecules expressed as gradients 
on retinal axons with opposing gradients on tecta! neurons. The gradient pattern is 
thought to be induced by a graded expression of transcription factors e.g. Pax?, 
Engrailed, inducing the cell surface Eph and ephrin family to play a predominant role 
in axon guidance (Knoll et al., 2001). 
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2. 4.4. Summary 
The Stem Cell Leukaemia (Sci) gene encodes a basic helixMloop~helix transcription 
factor that functions as a cell fate determinant in the haematopoietic system. Sci 
expression has been found in the central nervous system, predominantly in the 
mesencephalon but also in the diencephalon and metencephalon. A recent Sci gene 
deletion study has indicated that Sci is required for normal mid/hindbrain 
development. The Sc!-LacZ knockin reporter mouse has been developed for light 
microscopy analysi study the expression pattern of Sci in the brain. Further, a 
conditional yellow fluorescent (eYfp) reporter mouse for Sci expression has been 
generated using the Cre-loxP system. The mouse is an inducible model that generates 
fluorescence in Sc/ expressing cells upon tamoxifen administration. This mouse is 
bred for fluorescent and confocal analysis. 
The Pax7 gene encodes a transcription factor that contains a DNA binding domain 
called the paired box (Pax). Pax? also contains a homeodomain and conserved 
octapeptide sequence as well as a transactivation domain. Pax3, with a structure 
closely resembling that of Pax7 is thought to offer partial redundancy where 
expression domains overlap. The expression pattern of Pax7 suggests a functional 
role in the development of the neural crest, skeletal muscle and the central nervous 
system. During neurogenesis, Pax7 is part of the cascade that delineates the midbrain 
from the forebrain and Pax7 expressing cells are found in the ventricular zone where 
they migrate dorsally to the superior colliculus. 
Throughout embryogenesis, the expression of transcription factors is developmentally 
regulated to maintain differences in specific cell types and tissues. These factors bind 
to enhancer and promoter sequences of downstream genes to activate or repress gene 
expression. Gradients of opposing and overlapping expression act by mutual 
repression to maintain regional identity. This has been observed at the mid/hindbrain 
boundary and the mid/forebrain boundary from E8.5 to E12.5. Patterning differences 
specify cell commitment and cascades ultimately result in the formation of specific 
regions, as the superior colliculus does from the mid/hindbrain boundary. 
The Sci and Pax7 genes encode transcription factors that express in the brain during 
embryonic neurogenesis, suggesting they may play some organisational role in brain 
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development. Both factors continue to express in the dorsal layers of the superior 
colliculus in postnatal and adult brain. The spacio-temporal overl:l{) in expression 
suggests that Sci and Pax7 may be involved in related functions during brain 
development and in the adult brain. This study was undertaken to ascertain whether 
Sci and Pax7 were operating within the same cells during early neurogenesi.s through 
to adulthood, which then would suggest that they might be part of the same cascade 
in the development and/or maintenance of the mesencephalon. 
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3. MATERIALS AND METHODS 
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3.1 ETIDCAL CONSIDERATIONS 
Ethical approval was obtained for this study from the Edith Cowan University 
Animal Experimentation Ethics Committee. approval code: 04-A13 and from the 
Institute for Child Health Research Animal Experimentation Ethics Committee, 
approval code: AEEC #133. 
3.2 EXPERIMENTAL PROCEDURES 
3.2.1. Mouse Models 
• The Scl LacZ knockin mouse model on a C57BL/6J background has the LacZ 
gene knocked in to the Scllocus so that the expression pattern of Sci can be visualised 
for light microscopy once sections have undergone the ~-galactosidase enzyme assay. 
• The 0.9E3 Cre ER(T) transgenic mouse model on a C57BL/6J background 
has Cre recombinase fused to the 5' Sci neural enhancer (0.9E3) as well as an 
oestrogen receptor ligand-binding domain. Cre is then produced on the administration 
oftamoxifen only in Sci expressing neurons. This inducible model is crossed with the 
Rosa26 - eYfp knockin mouse and the double-positive offspring are used for 
fluorescent and confocal microscopy analysis. 
• The Rosa26- eYfp knockin mouse model has the enhanced Yellow fluorescent 
protein (eYf]l) knocked-in to the Rosa261ocus, a ubiquitous housekeeping gene, to 
achieve a high level of fluorescence in all Set expressing cells. A stop sequence 
flanked by LoxP sites precedes the Rosa26-e Yfp gene in this knockin mouse. The stop 
sequence is cleaved once Cre binds the loxP sites and e Yfp is expressed. By crossing 
the 0.9E3 CreER(T) mouse with the Rosa26- eYfp knockin mouse, a strong yellow 
fluorescent signal is produced in Set expressing neurons. Double-positive offspring 
are used for fluorescent and confocal microscopy analysis. 
All mice were bred and cared for at the Telethon Institute for Child Health Research 
on a 12h/12hr light/dark cycle with water and food available ad libitum. 
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3.2.2. Timedpregnancies 
To set up all timed pregnancies, female mice at least 6 weeks old received 
intraperitoneal (i.p.) injections of serum gonadotropin (Folligon; 2 units/O.lml PBS, 
Intervet Australia) 2 days before mating and with chorionic gonadotropin (Chorulon; 
2 units/0.1 ml PBS, Intervet Australia) 48 hours later. Fertile males were then added 
to the cage for one night. The following morning an external examination to detect a 
plug was performed on the females and the males were removed. For the LacZ timed 
pregnancies, both males and females were of heterozygote LacZ/wt genotype and 
heterozygote offspring were utilised for experiments. When results were analysed by 
fluorescent and confocal microscopy, a 0.9E3 CreER(T) transgenic mouse was 
crossed with a homozygous Rosa26- eYfp knockin mouse. Offspring with a double 
positive genotype were required to show Sci expression as yellow fluorescence 
because in these mice the fluorescent gene e Yfp is activated upon tamoxifen 
administration. 
3.2.3. Harvesting embryos 
To harvest embryos at specific timepoints, pregnant mice were euthanased at the 
required time of pregnancy by cervical dislocation. Embryos were then removed and 
placed in PBS, followed by dissection from the uterine horn and yolk sac. The 
embryo was decapitated and the head was immersed in 4% paraformaldehyde 
(Sigma) fixative for 2 hours on ice and the lower body was used for genotyping. After 
fixation of the head, the embryonic tissue underwent three washes in PBS for 15 
minutes, followed by immersion in 30% sucrose solution overnight at 4°C. Tissue 
was then cryofrozen the following morning in optimum cutting temperature 
formulation (OCT Compound; Sakura Finetek, USA) by immersion in liquid 
nitrogen. 
3.2.4. Tamoxifen Injections 
To induce the expression of e Yfp, 4-hydroxy-tamoxifen (Sigma) in corn oil was 
administered by intraperitoneal injection. Adult mice were given 2mg tamoxifen/ 0.2 
ml in corn oil each day for 5 consecutive days. A week was then allowed for the 
expression of eYfp to accumulate before perfusion of the adult mouse. For the P21 
timepoint, mice were given 0.5mg tamoxifen/0.5 ml in com oil for 3 consecutive days 
from postnatal day 16. For earlier timepoints, the pregnant female received the 
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tamoxifen injections at a concentration of 0.5mg tamoxifen/0.5 m1 in corn oil 
administered at El0.5 and lmg!O.lml at Ell.S for the El2.5 timepoint. At the El5.5, 
E18.5, E20.5 and P5 timepoints an amount of 1 mg/0.1 m1 tamoxifen was given on 
El2 and 2 mg/0.2 ml was given on E13. 
3.2. 5. Cross fostering of tamoxifen treated embryos 
To increase the survival of unborn pups from a tamoxifen injected female mouse 
during pregnancy, the embryos were born by Caesarean on E20.5 for the P5 
timepoints. The pregnant female was euthanased by cervical dislocation to prevent 
anaesthetic accumulation in the embryos. The unborn pups were harvested separately, 
assisted with the commencement of breathing and wet with excrements from a foster 
mother so as to be accepted by the new mother. These new foster mothers were from 
an ARC-Swiss background with white fur colour to facilitate 
recognition/identification from the cross-fostered pups with a dark fur colour in the 
new litter. 
Timed pregnancies were set up for the foster and the transgenic females so that a 
lactating foster mother would be available when the transgenic litter was due to be 
born. As the ARC Swiss foster mothers produce large litters they tend to give birth on 
E19.S so the ARC Swiss pregnancies were set up a day earlier than the transgenic 
mice. At the day of birth, about half of the ARC Swiss litter were culled or given to 
other ARC Swiss mothers and replaced by the newborn pups of the transgenic female. 
The neonatal care given by the foster mother was monitored for thirty minutes and 
followed by regnlar checks throughout the day. 
3. 2. 6. Anaesthetic 
Anaesthetics (O.lml/!Ogr body weight) were prepared using Ketarnine !OOmg/ml 
(Troy Laboratories) in conjunction with Xylazil 1 OOmg/ml (Troy Laboratories) and 
0.9% saline at a 4:1:5 ratio respectively. Ketamine is a dissociative anaesthetic while 
Xylazil provides sedation and analgesia. The anaesthetic was administered using a 
needle and syringe by the intraperitoneal (i.p.) route prior to perfusion. 
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3.2. 7. DNA Isolation 
Genotyping was performed on adult Sci LacZ knock-in and 0.9E3 CreER(T) mice at 
weaning age with DNA extracted from a tail tip. Mice were anaesthetised with the 
inhalant Methoxyflurane containing an analgesic, for tail tipping. l-2ml of 
Methoxyflurane was placed on a cotton wool pad in a bell jar and allowed to 
vaporise. The mouse was then placed inside the bell jar until fully anaesthetised. For 
the earlier postnatal timepoints, a tail tip was taken after the administration of the 
ketamine/xylazil anaesthetic and just prior to perfusion. The lower body of the 
embryo was used for genotyping following dissection from the uterine hom. 
The tail or embryo sample was placed in an ependorftube and O.Smllysis buffer was 
added, made up from O.IM Tris-HCl (pH8.5), 5mM EDTA (pH8.5), 0.5% sodium 
dodecyl sulfate, 0.2M NaCl and 82.5% autoclaved MilliQ H20 containing 20mg/ml 
Proteinase K (Roche). The tail sample was then digested overnight at 55°C by 
shaking at l200rpm in the ependorf thermomixer. The following morning, digested 
tails were centrifuged at 13200 rpm for 15 minutes to pellet undigested material. The 
supernatant was transferred to a new sterile tube and 0.5ml isopropanol added to each 
supernatant/tube. Tubes were mixed by inversion for 20-30 mins until a fine white 
pellet was seen floating in solution and then centrifuged at 13200rpm for 14sec. The 
isopropanol was poured off and lml 70% ethanol added. The inversion step was 
repeated for 20~30mins and centrifuged at 13200rpm for 14sec. The ethanol was 
poured off and any remaining ethanol carefully pipetted out of the tuhe. lOOul of 
lOmM Tris-EDTA buffer made up from lOmM Tris-Cl and lmM EDTA (pH 7.4) 
was added to each tube and the bottom of the tube was gently flicked about 4 times to 
dislodge the pellet from the side of the tube. Samples were shaken at 55°C at 
l200rpm in thermomixer for about l.5~2hours and then frozen at -20C until PCR was 
performed. 
3.2.8. Genotyping of genetically manipulated mice using Real-time PCR 
Amplified DNA was analysed by Real~time PCR assay using molecular beacons that 
are DNA hybridisation probes. The beacons have a stem and loop structure with the 
loop region being complementary to the target sequence and the stem region 
containing complementary arm sequences. Attached to one arm is a fluorescent 
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marker and to the other arm a quencher that dissipates energy from the fluorescent 
marker (Bustin, 2000). In this study the separate molecular beacons contain probes 
with complementary sequences to the LacZ gene (Fig. 3.1) and to the estrogen 
receptor region of CreER(T). The real-time primers amplify 1 OObp products for both 
Real-time PCRs. 
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Figure 3 .I Real-Time PCR primers amplify a I OObp product within the LacZ cassette that has been knocked into 
the Set gene. The molecular beacon hybridises to a sequence within the IOObp product and undergoes a 
conformational change that results in a fluorescent signal. 
The Cre and LacZ Real-time PCR assays included 35 cycles of activation (95° for 
600 seconds), denaturation (95°C for 15 seconds), annealing (55°C for 60 seconds) 
and extension (72°C for 15 seconds). During the annealing cycle, the molecular 
beacon loop underwent a conformational transition while hybridising with the target 
(Fig. 3 .2B). Hybridisation forced the stem apart thus separating the fluorophore and 
quencher and so creating a fluorescence signal that was detected and quantified 
during each cycle by the Real-time PCR machine. The amount of fluorescence 
correlated with the amount of amplified product and the genotype was determined 
using a threshold value. The threshold value for the LacZ molecular beacon ranged 
from 0.05 ·- 0.15 fluorescence with an average of 0.1 while the Cre molecular beacon 
ranged from 0.02 - 0.05 fluorescence. The threshold value was reached during the 
exponential phase of amplification (>20 cycles), being significantly different from 
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background values (Bustin, 2000). If the fluorescence level was beyond that of the 
threshold value then the sample was positive for the specific transgene while a lower 
than threshold value meant that the sample was negative for the gene. 
Figure 3.2 Real time PCR assay using a molecular beacon. (A) During the denaturation step the 
complementary arm sequences of the molecular beacon are denatured and the molecule fluoresces. (8) During the 
annealing phase the complementary stems will reanneal and the fluorophore will be quenched. However, in the 
presence of the target sequence, molecular beacons will also bind to the target and continue to fluoresce. (C) 
During polymerisation, the molecular beacon detaches from the target sequence, the arms reanneal and the 
fluorescence is again quenched. The intensity of the fluorescence is measured at the end of each cycle. 
Analysis of the LacZ positive animals was done using the molecular beacon (MB) 
(MWG Biotech) for LacZ (5' CAC GCG GTG GTC GGC TTA CGG TGA TTT 
CGC GTG 3'), a LacZ (MB) forward primer (5' CTG GGA CTG GGT GGA TCA 
GT 3') and a LacZ (MB) reverse primer (5' CTG GCG ATC GTT CGG CGT A 3'). 
The Cre (MB) (5'- CCG GCT CAA GCC CGC TCA TGA TCA AAC GCA GCC GG 
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.• 3'), ti1e Cre (MB) forward primer (5'- GAT ere GAG eeA TeT GeT G- 3') and 
the Cre (MB) reverse primer (5'- GGT eGG eeG TeA GGG AeA A- 3') were used 
to identify the double positive offspring from 0.9E3 CreER(T) transgenic mice 
crossed with the Rosa26- e Yfp knockin mice. 
3.2.9. Transcardial Perfusion for the fixation of brain tissue 
To isolate the brain of neonatal and adult animals, transcardial perfusion was 
performed. The ketaruine/Xylazil anaesthetic (O.lml/!Ogr body weight) placed the 
mouse into a deep coma and this was confirmed by a tail pinch test, the absence of 
corneal reflex and nonnal breathing. A peristaltic pump was used to pump fixative 
into the circulation of the mouse via a 25G butterfly needle inserted into the heart. 
The blood was first removed by a 40 second phosphate buffered saline (PBS) rinse 
and followed by 4% paraformaldehyde (Sigma) in PBS (pH 7.2) kept on ice, for 10 
minutes in neonates and 15 minutes in adult mice. Post-fixation was done after brain 
dissection in 4% parafonnaldehyde for 30 minutes on ice. Three 15-minute washes in 
PBS at room temperature followed post-fixation and then the brain tissue was 
cryoprotected in a 30% sucrose/PBS solution at 4°C overnight. (All mice were killed 
when the fixative circulated through the brain and body). 
3.2. 10. Ice Hypothermia and transcardial perfUsion of mouse pups 
Ice hypoth~nnia was used as an anaesthetic for the PO mice as they were too small to 
undergo i.p. injection. The technique provided immobilisation and mild analgesia and 
was effective due to the small surface area and body size. Pups were wrapped in a 
tissue to avoid freeze damage to the skin. The tissue was left open at the top to allow 
the pup to breathe and then the pup was placed in crushed ice for 3-4 minutes. During 
this time the pups became very pale. After performing the tail pinch test to confirm 
anaesthesia, transcardial perfusion commenced on a cooling platform to provide a 
constant level of hypothermia. Perfusion on pups was performed as described above 
for the adult. 
3.2.11. Frozen Blocks 
Following overnight cryoprotection in 30% sucrose solution, brain tissue was placed 
in cryomold biopsy specimen moulds (Tissue-Tek Cryomold Biopsy) and embedded 
with OCT. The moulds were frozen on liquid nitrogen and stored at -80°C for later 
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analysis. Frozen tissue was sectioned into 20J,tm serial sections and mounted onto 
SuperFrost Plus slides (Menzel-glaser, Germany) using a Leica cryostat (CM3050). 
3. 2.12. LacZ histochemistry 
Slides mounted with 20J,tm serial brain sections were air-dried for 30 minutes prior to 
the commencement of the LacZ staining procedure. The wash buffer was made just 
prior to use from 5mM EGTA (pH 8), 0.01% deoxycholate, 0.02% NP-40, 2mM 
MgCh, 20mM Tris (pH 7.3) and lx PBS (pH 7.2). Slides were rinsed in the wash 
buffer on the orbital shaker for 3 x 20 minutes with a change of wash buffer each time. 
The slides were then incubated at 3rC in the staining solution overnight in a dark 
location. The staining solution was made up from the SmM K3Fe(CN)6, SmM 
K,Fe(CN)6, 5mM EGTA (pH 8), 0.01% deoxycholate, 0.02% NP-40, 2mM MgCh, 
20mM Tris (pH 7.3), lx PBS (pH 7.2) and lmg/ml 5-Bromo-4-chloro-3-indolyl ~-D­
galactopyranoside (X-gal) (Sigma) inN, N-dimethyl fonnamide (40mg/ml). 
The following day, slides were rinsed in PBS for 5 minutes and then dehydrated 
through an ethanol series- two minutes each in 70%, 90%, 100% and 100% followed 
by two changes in Histoclear (National Diagnostics) for two minu~es each. The slides 
were coverslipped in Permount mounting medium (ProScitech) to prevent the LacZ 
staining from dissolving. When LacZ histochemistry was followed by 
immunoperoxidase staining, dehydration was delayed and immunoperoxidase staining 
commenced. 
3.2.13. Immunohistochemistry of mouse brain tissue for antibodies 
raised in mice 
The Vector MOM Immunodetection kit (Perth Scientific) was used for the Pax7, 
NeuN and Doublecortin (Dcx) antibodies as the kit is specifically designed for 
antibodies that have been raised in mice. Slides of 20J,tm serial brain sections were 
initially rinsed in PBS for 15 minutes and then the endogenous peroxidases quenched 
with a 0.6% H202 in PBS solution for 20 minutes. This was followed by 3 x 15 minute 
PBS washes. An avidin block (4 drops of Avidin stock solution in 1000~1 of PBS) 
was performed for 15 minutes followed by a 15-minute biotin block (4 drops of Biotin 
stock solution in 1000~1 of PBS) using the Vector Avidin/Biotin Blocking Kit, with 
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both blocks rinsed afterwards for 5 minutes in PBS. The sections were further 
incubated for one hour in the Vector MOM mouse lg blocking reagent (l drop in 
1250~1 PBS) and washed 3 x IS minutes in PBS. The primary antibody was added to 
the antibody diluent at a concentration of I :I 0 (Pax7), I :500 (NeuN) and I :100 (Dcx). 
The antibody diluent was made up from a ratio of 300!11 ofPmtein Concentrate stock 
solution (MOM kit) to 3750~-tl of PBS. The slides were drained of excess fluid and the 
primary antibody in antibody diluent added to the sections, covered with parafilm and 
incubated overnight in a hwnidified chamber at 4 cc. 
The following day, the sections were rinsed 3 x 15 minutes in PBS. The biotinylated 
a-mouse IgG reagent secondary antibody was diluted in the antibody diluent at 1:250 
and incubated at room temperature for 2 hours. This was then rinsed 3 x 15 minutes in 
PBS. Sections were then incubated in the VECTASTAIN Elite ABC reagent (1drop of 
reagent A and 1 drop of reagent B to 1250!11 PBS) for one hour at room temperature 
followed by 3 x 15 minute washes in PBS. The chromogen diaminobenzidine 
tetrahydrachloride (DAB); (DAB Substrate J:(it for Peroxidase, Vector Laboratories) 
was made up by adding 1 drop of Buffer Stock Solution to 2500!11 of distilled water 
and mixed well. Then 2 drops of DAB Stock Solution were added and mixed followed 
by one drop of Hydrogen Peroxide solution, which was added and then mixed. DAB 
was visualised for colour from 2-10 minutes and the reaction stopped with the 
addition of PBS. Slides were then given 3 x 15 minute washes in PBS, sections 
flattened with a brush if required and left to dry for 30 minutes to an hour. The 
sections were then dehydrated through an ethanol series- two minutes each in 70%, 
90%, 100% and 100% followed by 2 x 2 minutes in Histoclear (Scott Scientific). 
Sli<les were then coverslipped with Perrnount to prevent the LacZ staining from 
dissolving. 
3.2.14. Immunofluorescence for Pax7 
To assess co-localisation of Pax7 and Scl in tissue sections by fluorescent and 
confocal microscopy, the following immunofluorescent protocol was performed for 
Pax?. Tissue sections were initially rinsed in PBS for 15 minutes followed by an 
incubation of the Pax? primary antibody diluted 1:10 in standard antibody diluent of 
1% Bovine Serum Albumin (BSA) and 0.2% TritonX-100 in PBS. Sections were 
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covered with parafilm and incubated in a dark humidified chamber overnight at 4°C. 
The following day, the primary antibody was rinsed with 3 x 15 minute PBS washes 
and then the secondary antibody, Cy3 goat a-mouse IgG (Jackson ImmunoResearch 
Laboratories), having been diluted in the same standard antibody diluent at 1:300, was 
incubated at room temperature for 2 hours. The tissue sections were then given 3 x 15 
minute washes in PBS, sections were drained of excess fluid and then coverslipped 
using Vectashield Mounting Medium (Vector Laboratories). Nail polish was painted 
around the coverslip to seal in the mounting medium and slides were stored in the 
dark at 4°C. 
3. 2.15. Microscopic Analysis 
Light and fluorescent microscopy was performed on a Leica DMLB microscope and 
photographs were taken with a Leica colour digital camera DC300. Confocal analysis 
was achieved on a Bio-Rad MRCIOOO confocal microscope at the Centre for 
Microscopy and Microanalysis at the University of Western Australia. The aim of this 
project was to look at the overlapping expression regions of Sci and Pax7 from 
embryonic neurogenesis through to adulthood to assess co-expression between the two 
factors. The results reported in this study were not semi-quantitated by cell counting 
or density analyses. 
3.2.16. Research Design 
Sc/ & Pax7 Co-localisation 
The seven different timepoints were selected to follow the expression patterns of Sci 
and Pax7 during the formation of the brain and in particular the development and 
subsequent innervation and lamination of the superior colliculus. Five to six timed 
pregnancies of Scl-LacZ knockin female mice were set up at each timepoint with an 
average of two embryonic/early postnatal litters produced. This was consi~tent with 
the 40% pregnancy rate previously achieved in the Cancer Biology Lab f,( the 
Telethon Institute for Child Health Research. The resulting litters were tlx:ed vvith 4% 
parafonna!dehyde at the timepoints of embryonic day (E) 12.5, El5.5 and El8.5. 
Perfusion was performed on two litters of mice at postnatal day (P) 0, PS, at weaning 
(P21) and in three adult mice (Fig 3.3). After brain fixation with 4% 
paraformaldehyde and overnight cryoprotection in 30% sucrose, the brains were 
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cryofrozen in liquid nitrogen and stored at -80°C. Once genotyping had been 
performed to detect the presence of the LacZ gene, mouse brains were sectioned at 
20!-t-m and mounted on SuperFrost Plus slides. Analysis of ~-galactosidase and Pax7 
immunohistochemistry were performed to indicate the expression patterns of Pax7 
and LacZ. Sections were also stained with the neuronal cell markers NeuN (Mullen 
et al. , 1992) and Doublecortin (Rao & Shetty, 2004) to indicate neuronal subtypes 
within regions of co-localisation. Analysis was initially performed using light 
microscopy and confirmed by confocal microscopy. 
Timed E12.5 15.5 18.5 PO P5 P21 Adult 
Pregnancies 
l lllll l l 
Figure 3.3 Timepoints for LacZ co-localisation studies. Timed pregnancies were set up and two litters each from 
the E l2.5, E15.5, El8.5, PO, P5 and P21 timepoints were sacrificed for Sci and Pax7 expression studies for light 
microscopy analysis. Three adult mice were perfused. 
For confirmation of co-localisation usmg confocal microscopy, the fluorescent 
transgenic mouse model was used to display the pattern of Scl expressing cells in the 
CNS. Inducible 0.9E3 CreER(T) mice were crossed with R26R e Yfp mice so that 
fluorescence could be visualised in Sci expressing neurons. Five to six timed 
pregnancies were set up with an average of two embryonic/postnatal litters produced 
per timepoint. To induce the e YJP expression in the brain, pregnant mice were given 
tamoxifen at 0.5mg/0.5 ml at E10.5 and lmg/O.lml at El1.5 for the El2.5 timepoint 
and 1 mg/0.1 ml was given on El2.5 and 2 mg/0.2 ml was given on El3.5 for the 
E l5.5, E18.5, E20.5 and P5 timepoints. For the P21 timepoint, mice were given 
0.5mg/ml in corn oil on P17, Pl8 and Pl9. Adult mice were given 5 daily if1iections 
of lmg tamoxifen/ 0.1 ml in corn oil one week prior to perfusion (Fig. 3.4). 
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For the PO timepoint, mothers were sacrificed and given a caesarean at E20 as it had 
been previously noted that some mothers had difficulty giving birth after tamoxifen 
injections. The E20 litters were not perfused but were fixed in 4% paraformaldehyde 
as with the earlier embryonic timepoints. For the PS timepoints, mothers were 
sacrificed at E20 and after caesarean the pups were cross-fostered to ARC-Swiss 
mothers whose time pregnancies had been set up a day earlier. Once these pups 
reached PS they were perfused, the brains fixed in 4% paraformaldehyde and then 
cryoprotected and cryofrozen. Genotyping was performed by RTPCR of DNA 
isolated from tail tips to determine the required genotype, 0.9E3 CreER(Tt, R26R 
e YJP +lw. The brains of positively identified animals were then cryosectioned and the 
immunofluorescent antibody staining method was performed to detect Pax 7 
expression. Microscopic analysis was done using fluorescent microscopy with e Yfp 
expression detected as yellow autofluorescence and Pax 7 expression as red 
fluorescence. The co-localisation of Pax7 and e Yfp expression was assessed with 
confocal microscopy. Cells that fluoresced orange were interpreted as cells in which 
yellow and red fluorescence had merged therefore co-expressing e Yfp and Pax7. 
eYfpTimed 
Pregnancies 
ArcSwiss 
timed 
El2.5 15.5 18.5 20.5 P5 
(Caesarean) 
pregnancies for E12.5 
Tamoxifen 
(I mg/0.1 ml- El2.5) 
(2 mg/0.2 ml - El3.5) for EIS.S. EIB.S. E20. PO and PS 
P2l 
Tamoxifen 
(O.Smglml Pl7. 18 . 19) 
forP21 
Tamoxifen 
(0.1 mg/ml for 5 days 
prior to perfusion) 
Adult 
Figure 3.4 Timepoints for e Yfp co-localisation studies. ARC Swiss timed pregnancies were set up a day prior to 
the 0.9E3 CreER(T) x GTRosa26 e Yfp. The brown arrows represent the days of embryo harvesting, caesarean 
section (E20) and perfusion. The green arrows represent the days oftamoxifen injections for different timepoints. 
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4.RESULTS 
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To assess the expression patterns of Sci and Pax7 from embryogenesis into 
adulthood, 201J.m brain sections- were stained and analysed at seven different 
timepoints from embryonic day (E)l2.5, ElS.S, El8.5, PO, PS, and P2l through to the 
adult brain 
4.1 LACZ STAINING 
The expression pattern of Sci was visualised by light microscopy after the {)-
galactosidase enzyme assay (LacZ staining) had been performed on sections. The 
resulting blue staining was observed as small blue dots in the cytoplasm, possibly 
held within the Golgi apparatus as a non-functional protein. The overall Sci 
expression pattern was similar to that previously described (van Eekelen et al., 2003). 
Embryonic LacZ staining was often found to be weaker than staining in postnatal and 
adult brain regions. As embryonic tissue was not perfused, the 4% paraformaldehyde 
did not enter the circulation and so the difference in brain fixation may have possibly 
affected the quality ofLacZ staining. 
LacZ staining could be combined with Pax? immunoperoxidase staining for light 
microscopy analysis. However, background produced by the peroxidase reaction used 
to detect Pax? was too high if the combined staining procedure was performed on 
embryonic tissue. Moreover, in postnatal tissue where Pax? expression was most 
intense in dorsal superior colliculus, LacZ staining seemed compromised when 
combined with Pax? immunohistochemistry. This occurred at the PO and PS 
timepoints with the LacZ staining found paler when compared to controls. Strong 
blue staining was observed expressed in other brain regions on the same section but 
high magnification was needed to detect LacZ within dorsal superior colliculus. As 
the LacZ staining was not affected in tissue regions where Pax? expression was not 
found then the paler staining is unlikely to be a technical problem (personal 
observation). 
4.2 PAX? STAIN!NG 
Pax7 immunoperoxidase staining was observed as specific nuclear staining at all 
timepoints. The increased background observed at embryonic timepoints may be 
explained by differences in tissue, perhaps from increased amounts of peroxidases 
found within embryonic tissue. The observed expression pattern of Pax? has been 
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partially detailed in a previous report (StoykOva and Gruss, 1994). Experiments 
performed here have greatly extended knowledge of the Pax7 expression profile 
throughout diencephalon, mesencephalon and metencephalon at several timepoints 
during development and postnatally. 
4.3 FLUORESCENT AND CONFOCAL MICROSCOPY 
With Pax7 expression observed as nuclear staining and Sci expression as small blue 
dots in the cytoplasm, co-expression could not be confirmed by light microscopy. 
Although within a large population of the cells co-expression appeared likely, the 
adjacent blue staining may have come from an adjoining cell or one sitting directly 
above the Pax7 expressing cell. Confirmation of co-localisation was therefore 
assessed by confocal microscopy that analysed sections at different focal depths. The 
series of virtual sections along the Z-axis were then overlayed for 3D visualisation 
using the Comas software. eYfp fluorescence reflecting the Set expression pattern 
was seen under a fluorescent microscope as green nuclear staining while Pax? 
expression was seen as red nuclear staining. When detecting the cell co-expression of 
eYfp and Pax? under the confocal microscope, orange cells were observed from the 
merging of cellular expression whereas adjacent cells expressing eYfp and Pax? 
remained green and red. Unfortunately at most embryonic timepoints, the eYfp 
fluorescent signal did not reach the threshold levels necessary to visualise specific 
nuclear staining and so co-expression could not be confirmed at some of the earlier 
timepoints. The lower than threshold fluorescence was probably a result of the 
reduced timeframe in which the embryo had to generate fluorescence after tamoxifen 
administration. The tamoxifen was also given. in reduced concentrations so as not to 
be detrimental to the embryos. The best fluorescent results for the eYfp protein were 
seen in the adult brain after five days of tamoxifen administration and a week was 
allowed for the accumulation of the fluorescence protein. However, in most cases the 
expression patterns of Sci and Pax7 during embryonic neurogenesis were not found in 
the same regions and co-localisation was not suggested. 
4.4 NEURONAL MARKERS 
Some sets of sections having undergone LacZ histochemistry were also stained for 
the neuronal markers Doublecortin (Dcx) and Neuronal Nuclear Protein (NeuN) in 
order to identify the neuronal cell phenotype. Within the brain, NeuN is neuronal 
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cell-type specific and its expression initially appears at a time between the neuron 
progenitor cell leaving the proliferative phase of neurogenesis and the 
commencement of terminal differentiation. The expression continues in the mature 
fully differentiated neuron. In most neurons, NeuN immunoreactivity stains the 
nucleus however staining has been observed in the cytoplasm and even the processes 
of some neurons (Mullen et al., 1992). The neuronal marker Doublecortin (Dcx) is a 
microtubule-associated phosphoprotein (MAP) that is used as a marker to identify 
newly born neurons (Rao, 2004). The expression of Dcx is found in cells that are 
tangentially migrating with the strongest signal seen in both the soma and the leading 
processes of neurons (Francis et at., 1999). Dcx expression continues in the neuron 
during differentiation including the early growth period where dendritic and axonal 
growth is taking place. Some degree of overlap has been observed between Dcx and 
the mature neuron marker NeuN owing to the extended period of expression of Dcx. 
(Rao, 2004). Dcx expression normally ceases within 21 days after the birth of the 
neuron (Francis et al., 1999). 
In this study, at the P21 timepoint, possible co-localisation of Sci with NeuN was 
seen in the superior colliculus but not in all cells as observed in the adult brain. 
Possible Sci co-localisation with Double-cortin (Dcx) in the dorsal superior 
colliculus, rostral inferior colliculus, the lateral interpeduncular nucleus and the 
posterior hypothalamic area was also observed whereas the control slide showed no 
specific staining. This would suggest that not all Sci expressing cells had fully 
differentiated into mature neurons at this time and some were still in an immature 
neuron state as indicated by their possible co-localisation with Dcx . . However, 
neurogenesis is thought to be complete a few days prior to birth and the Dcx marker is 
meant to cease expression within 21 days after the birth of the cell. Our observation 
may indicate that Dcx was expressed for longer than 21 days after the birth of the cell 
which contradicts the current literature (Rao, 2004). On the other hand it may suggest 
that neurogenesis still occurs at a later stage than originally thought for which we do 
not have any further evidence. Maybe the most likely explanation would be that the 
staining observed was not indicative of Dcx expression for some technical reason. 
Unfortunately we were unable to co-stain NeuN and Dcx with Pax7 as the primary 
antibodies are all monoclonal and raised in mouse and therefore cannot be 
differentiated from each other with the a-mouse secondary antibody in the 
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Neuronal 
Markers 
Figure 4.1 Expression patterns of Sci (blue) and NeuN (brown) at the P2 1 (A and B) and the PS timepoints (C). 
Photomicrograph A illustrates Sci and NeuN staining in the superior colliculus and shows evidence of co-
localisation in the vast majority of ce ll s but not all. Photomicrograph B is a lower magnification of A. 
Figure 4.2 Express ion patterns of Sci (b lue) and the immature neuronal marker Dcx (brown). 
Photomicrograph A implies co-localisation between Sci and Dcx in the s uperior colliculus in nearly every 
Sci expressing cell at the P2 1 t imepoint. Photomicrograph B is a lower magnificat ion of A. 
Photomicrograoh C illustrates oossible co-localisation between Sci and Dcx in the interoeduncular region 
,. 
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immunohistochemical staining procedure. Immunohistochemistry using mouse 
monoclonal antibodies in a sequential manner has previously been performed but the 
results have displayed ambiguity. Dcx staining at the embryonic timepoints resulted 
in a great deal of background that did not allow for specific analysis whereas the 
postnatal staining was more effective and was found to co-localise with Scl. The 
neuronal marker co-staining was not pursued as the results were inconsistent, they 
could not be performed in combination with Pax? and therefore they did not add to 
this research. 
4.5 MAPPING OF EXPRESSION PATTERNS IN THE BRAIN 
The expression patterns were determined in the adult and P21 brains using the 
Paxinos and Franklin mouse brain atlas (Paxinos and Franklin, 2001). For the earlier 
timepoint, mapping was established with the aid of prenatal mouse brain atlas 
(Schambra et al., 1992). The P21 and adult brain expression patterns were found to be 
the same and· so wi11 be described and discussed as one timepoint. Unfortunately, 
there is no brain map available for the early postnatal period. Despite the fact that the 
anatomy of the P5 brain has not fully matured at this age, the adult mouse atlas was 
used in the absence of a better alternative. For analysis of the PO timepoint, the 
embryonic day 18 map was utilised. All analysis was done in the saggital plane and 
postnatal expression patterns have been described firstly at the midsaggitallevel close 
to midline. The description then extends laterally to the midpoint of one hemisphere 
followed by the most lateral expression domains of Scl and Pax?. As the embryonic 
brain is smaller, the description of expression patterns is all encompassing. 
As the Sci expression pattern is more extensive and described in great detail by van 
Eekelen et al (2003), the description in these results will only depict regions of 
expression where Scl and Pax? are both found and where there is expression variation 
between different timepoints. During brain development, four main brain regions will 
be discussed where both Scl and Pax? are expressed. 
46 
E12.5 
timepoint 
Figure 4.1 Expression patterns of Sci and Pax 7 at E 12.5. The schematic drawing in the centre represents 
Sci (blue) and Pax7 (pink). Indicated frames labelled A-C refer to the location of photomicrographs 
inc luded in this figure. Photomicrograph A illustrates Sci expression in the posterior commissure (PC) 
and developing pretectum (PT) as analysed by confocal microscopy (indicated by yellow/green staining 
in the cell cytoplasm). Note some early migratory Pax7 positive cells indicated by red staining in cell 
nucleus (arrows). Bright red staining of pia is cons idered non-specific. No co-localisation of Pax7 and 
Sci based on the absence of red and green staining merged to orange is evident in this reg ion. 
Photomicrograph B highlights Pax7 expression in the subthalamus (SUT) and pons (PN) region around 
the mesencephalic flexure (MF) as analysed by confocal microscopy. Photomicrograph C l and C2 
illustrate Pax7 expression. in the isthmus ( IS) as analysed by confocal microscopy (CJ) and light 
microscopy (C2), with brown nuclear immunoreactivity. 
47 
As several different maps have been utilised to describe expression patterns, often 
these regions have structures that are different by name according to their level of 
development. For ease of identification, especially in the embryonic brain they will be 
described as the tectum (developing superior colliculus), the developing pretectal area 
and the developing tegmentum and rostral hindbrain. 
4.6 E12.5 TIMEPOINT 
Peak cell generation occurs between E12 to El3 for the superficial layers of the 
superior colliculus during embryonic neurogenesis (Edwards et al., l986b). Pax7 was 
not found in the developing tectum (superior colliculus) at this timepoint but was seen 
in a small region of the subthalamus and in a broad expression region of high 
intensity within the isthmus (Fig. 4.IB). Dorsally, Sci expression was found in the 
developing tectum at the most dorsal layer, the posterior commissure, pretectum (Fig. 
4.1A) and the tegmentum. The overlap ofScl and Pax7 was seen in the region of the 
isthmus but with no indication of co-localisation after confocal analysis. These results 
were confirmed in three separate mice by performing both (immuno)histochemical 
and immunofluorescent staining for light microscopy and confocal microscopy. 139 
sections underwent (immuno)histochemical staining for the mapping analysis at the 
El2.5 timepoint. 
4.7 E15.5 TIMEPOINT 
At El5.5, retinal ganglion cell projections are beginning to innervate the superficial 
layers of the superior colliculus (Edwards et al., 1986b). At this timepoint, Pax7 
showed high expression in the dorsal ventricular zone with Pax7 expressed in nearly 
every cell. From this region, scattered Pax7 expressing cells were seen to migrate 
dorsally into the tectum from the ventricular zone (Fig. 4.2B). The scattered 
migrating cells were found throughout the superior colliculus and inferior colliculus. 
Pax7 expression was also found in the rostral hindbrain in the region ventral to the 
dorsal raphe between the mesencephalic flexure and the aqueduct (Fig. 4.2C). More 
rostral, a small region of Pax7 expression was found in the caudal thalamus. 
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timepoint 
AQ 
4V 
Figure 4 .2 Expression patterns of Sci and Pax7 at E 15.5. The schematic drawing in the centre represents 
Sci (blue) and Pax 7 (pink). Indicated frames labelled A-D refer to the location of photomicrographs 
included in this figure. Photomicrograph A illustrates possible co-localisation of Sci and Pax7 within the 
developing pretectum (PT). Co-localisation could not be confirmed in this region with confocal 
microscopic analysis, as thee Yfp threshold was not reached. Photomicrograph B illustrates a high level of 
Sci express ion in the most dorsal layer of the superior colliculus (DSC) while Pax7 is expressed in nearly 
every cell in the dorsal ventricular zone. Scattered Pax7 cells are observed migrating dorsally. 
Photomicrograph C illustrates fluorescent Pax7 staining between the mesencephalic flexure (MF) and the 
aqueduct (AQ). Photomicrograph D 1 finds Pax7 and Sci expression overlapping in the tegmental region 
with Sci in caudal tegmentum and rostral hindbrain (RH) lining the fourth ventric le (4V) and Pax7 
. extending into the developing rostral hindbrain. Photomicrograph D2 is the higher magnification of D I 
showing the overlap but not co-localisation of Sci and Pax7. 
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Sci expression displayed a high level of expression in the most dorsal layer of the 
superi1>r colliculus and was also found expressed in the inferior colliculus. Sci 
expression was seen in the subventricular zone of the dorsal tegmentum. No co~ 
localisation between Sci and Pax7 was indicated in the superior colliculus at this 
timepoint. Similarly, Expression of both Sci and Pax 7 showed possible co-
localisation within the developing pretectum in the posterior commissure (Fig. 4.2A) 
but with no co-expression in the developing tegmental region (Fig. 4.2D 1, D2). These 
results were confirmed after performing (immuno)histochemical and 
immunofluorescent staining on three separate mice. 261 brain sections were 
(immuno)histochemically stained for the E15.5 mapping analysis. 
4.8 E18.5 TIMEPOINT 
In the superior colliculus at E18.5, a large population of retinal ganglion cell axons 
have penetrated all the superficial layers, and cell migration from the ventricular zone 
to the superior colliculus is almost complete (Edwards et al., 1986b; Edwards et al., 
1986a). In similar patterning to that at El5.5, Pax? expression was seen scattered 
throughout the developing superior colliculus (Fig. 4.3B) extending to the inferior 
colliculus. Pax7 expression also extended from the interpeduncular region (Fig. 
4.3D2) to the rostral hindbrain region along the fourth ventricle crossing the 
preswnptive median raphe region in the tegmentum. Pax? was again found expressed 
in the caudal thalamus (Fig. 4.3C). 
Sci expression was seen in the dorsal most layer of the superior colliculus close to the 
midline (Fig4.3B). At the level of the dorsal raphe, Sci was found in the dorsal region 
while Pax? was seen in the ventral area. The rostral hindbrain region displayed 
overlapping expression but with no co-expression. For expression patterns at El8.5 
three mouse brains were utilised for light microscopy analysis and two were utilised 
for fluorescent and confocal microscopy. A total of 132 brain sections were 
immunostained at the El8.5 timepoint. 
4.9 PO TIMEPOINT 
The PO timepoint is a time of great activity within the superior colliculus as 
previously described in the literature. Innervation of the retinal axons is near 
completion and the superior coiliculus undergoes extensive radial growth. 
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E18.5 
timepoint 
DSC 
Figure 4.3 Expression patterns of Sci and Pax7 at E 18.5. The schematic drawing in the centre represents Sci 
(blue) and Pax7 (pink). Indicated frames labelled A-D refer to the location of photomicrographs included in 
this figure. Photomicrograph A I displays Pax7 fluorescent staining in the developing pretectum (PT) and A2 
illustrates Sci LacZ staining in the same region using light microscopy. Photomicrograph B illustrates high 
density Sci expression in the dorsal superior colliculus (DSC) and evenly scattered Pax7 staining throughout 
the superior colliculus extending to the inferior colliculus (IC). Photomicrograph C illustrates the small 
expression area of Pax7 in rostral thalamus with fluorescent staining. Photomicrograph 01 disp lays Pax7 
fluorescent staining in the interpeduncular (JPL) region extending toward the fourth ventricle and 02 illustrates 
Pax7 and Sci expression surrounding the mesencephalic flexure (Mf) with Pax7 expression in caudal thalamus 
(TH) and the interpeduncular region. There is no co-local isation suggested between the two expression 
patterns at this timepoint. 
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Figure 4.4 Expression patterns of Sci at E20.5 and Pax7 at PO. The schematic drawing in the centre 
represents Sci (blue) and Pax7 (pink). Indicated frames labelled A-D refer to the location of 
photomicrographs included in this figure. Photomicrograph A illustrates a strong band of Pax7 
expression in the pretectum (PT). Photomicrograph B I shows Pax7 and Sci in the dorsal superior 
colliculus (SC). Pax7 expression is in high density throughout the dorsal superior colliculus at this 
timepoint and extensively throughout all the superior colliculus layers Photomicrograph 82 is a higher 
magnification of B l. Note the pale LacZ staining amongst the dense Pax7 staining. Photomicrograph C 
illustrates an overview of Pax7 fluorescent staining in caudal superior colliculus and in rostral hindbrain 
showing expression along the almost mature mid/hindbrain boundary. Photomicrograph D shows the 
high density fluorescent Pax7 staining between the interpeduncular (IPL) nucleus and the fourth ventricle 
· (4V). 
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At this stage dense fibre bundles are present throughout all layers of the superior 
colliculus (Edwards et al., 1986b). Similar expression patterns were seen for Pax7 at 
PO as in the earlier timepoints but with extensive Pax7 expression found throughout 
the superior colliculus and high density staining found within the dorsal layers (Fig. 
4.481, 82). In rostral hindbrain, Paxl expression was found in the rostral part of the 
dorsal tegmental nucleus and caudal dorsal raphe (Fig. 4.4C). Paxl expression was 
also found ventral and within the interpeduncular nucleus (Fig. 4.4D). Paxl 
expression continued to be seen in a line of expressing cells from the mesencephalic 
flexure to the fourth ventricle along the almost mature mid/hindbrain boundary. The 
confined circle of Paxl expression consistently seen from the E12.5 timepoint was 
again found in the ventral thalamic region. 
At PO, Sci expression in the superior colliculus increased into the deeper layers but 
not to the same extent as that observed for Pax7 expression in this region Sc/ was 
found more restricted to the most dorsal layers extending to the pretectum at a close 
to mid-saggital level. Sci was also found in the dorsal tegmental nucleus and the 
dorsal raphe where expression overlapped that of Paxl but did not co-localise. A line 
of expressing cells for both factors was seen rostral to the dorsal raphe with a degree 
of overlap near the third ventricle. At sections more lateral from midline, Sci and 
Pax7 expression became denser in the pretectum (Fig. 4.4A). In the most lateral 
sections displaying both factors, Sc/ was again limited to the most dorsal layer of the 
superior colliculus while Pax7 expression remained extensive throughout the superior 
colliculus with a high density seen in the dorsal layers. For analysis at the PO 
timepoint, three mouse brains were assessed using light microscopy and two mouse 
brains at E20.5 were assessed with fluorescent 311d confocal microscopy. In all, 217 
brain sections were (immuno)histochemically stained for the mapping at the PO 
time point. 
4.10 PS TIMEPOINT 
During the early postnatal period there is considerable radial growth in the superior 
colliculus and for the first 6 postnatal days fibre bundles are removed from the 
superficial grey layer while those in the optic layer remain. At the sa."!le time, 
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Figure 4.5 Expression patterns of Sci and Pax7 at PS. The schematic drawing in the centre represents Sci 
(blue) and Pax7 (pink). Indicated frames labelled A-D refer to location of photomicrographs included in 
this figure. Photomicrograph A illustrates fluorescent Pax7 staining in the pretectum. Photomicrograph 8 I 
displays Pax7 fluorescent sta ining with extensive expression throughout the superior colliculus (SC). Note 
the rostro-caudal bands of Pax7 expression seen within the layers of the superior colliculus in fluorescent 
and 82 in light microscopy of Pax7 and Set staining in the superior colliculus. Photomicrograph C 
illustrates the Pax7 and Sci overlapping expression in the region of the laterodorsal tegmental nucleus 
without co-expression. Photomicrograph D I shows fluorescent Pax 7 staining at the interpeduncular 
nucleus (TPL) and 02, light microscopy of Pax7 expression seen from the interpeduncular nucleus to the 
fourth ventricle. 
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connections from axons in the optic layer extend and arborise the superficial grey 
layer (Edwards et al., 1986b). 
Strong Pax7 expression was found in the superficial layers (zonal, superficial grey 
and optic layer) of the superior colliculus and a medium density expression was found 
throughout the intennediate and deeper layers (Fig. 4.5Bl, B2). Rostra-caudal bands 
of Pax7 expression were seen within the layers of the superior colliculus. This is 
probably an indication that lamination has occurred. Unfortunately without a specific 
map for the PS timepoint, it was difficult to ascertain the ~recise layers of the superior 
colliculus where the rostra-caudal bands were found expressed. The caudal high, 
rostral low gradient across the dorsal layers of the superior colliculus and the dorsal 
high, ventral low gradient across the superior colliculus (Fig. 4.6A4) was seen as 
described by Thomas et al, 2004. A strong pretectal expression (Fig. 4.5A) was also 
observed and a stream of stained cells seen expressed from the interpeduncular 
nucleus (Fig. 4.501) to the fourth ventricle (Fig. 4.5D2) although much narrower 
than seen at earlier timepoints. The similar circle of Pax7 expression was again found 
in the caudal thalamic area of the posterior hypothalamus. 
Scl expression was found more widespread within the superior colliculus at this 
timepoint (Fig. 4.5B2) and Sci was also found expressed in the cortex of the inferior 
colliculus. A strong pretectal expression was observed with possible co-localisation 
between Sci and Pax7. Scattered Sci cells were found dorsal to the line of Pax7 
expression from the interpeduncular nucleus to the fourth ventricle crossing median 
raphe but with no evidence of co-localisation. Both factors were expressed in the 
interpeduncular nucleus but again with no co-localisation confirmed. Overlapping 
expressions for Scl and Pax7 was also found in the laterodorsal tegmental nucleus 
(Fig. 4.5C) with Pax7 expressing ventrally and Sci dorsally with no indication of co-
localisation. For analysis at the PS timepoint, three mouse brains were assessed for 
light microscopy and three for fluorescent and confocal microscopy. 175 brain 
sections were (immuno)histochemically stained for light microscopy mapping 
analysis for the PS timepoint. 
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Figure 4.6Expression patterns of Sci and Pax7 at P21 and in the adult brain. Both timepoints are taken 
together as the expression patterns and morphology at P21 and in adult b rain was found alike. The 
schematic drawing in the centre represents Sci (blue) and Pax7 (pink). Indicaned frames labelled A-B refer 
to the location of photomicrographs included in this figure. Pax 7 expression is restricted to the dorsal 
midbrain and a small region of expression in rostral hindbrain at these time.points. Photomicrograph A I 
illustrates Sci and Pax7 expression in the dorsal layers of the superior collic ulus indicating possib le co-
localisation. Photomicrograph A2 is higher magnification of A I. Photomicrograph A3 displays P21 
confocal analysis of a high population of cells within the dorsal superior collliculus co-local ising Sci and 
Pax7. (Sci - green, Pax7 - red, co-localisation - orange) Photomicrograph A4 showing a strong Pax7 
fluorescent s ignal seen in a caudal high, rostral low gradient in the dorsal layers of the superior colliculus. 
Photomicrograph B illustrates the overlapping but not co- localising Sci a nd Pax7 ex pression at the 
laterodorsal tegmentum (LDTg). This expression region in the rostral hindbrain is reduced from that at 
earlier timepoints. 
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4.11 P21 AND ADULT TIMEPOINT 
Remarkably. the expression patterns at postnatal day 21 and in the adult brain were 
found to be the same in every region for both Sci and Pax?. Pax? expression was 
found in a more restricted expression domain than that of Sci in the mature mouse 
brain. 
Pax7 was also reduced when compared to the Pax? embryonic expression pattern 
although with continued high expression in the dorsal superior colliculus. Expression 
was found within the superior colliculus, a few Pax? cells were found expressed in 
the inferior colliculus, the medial pretectal nucleus, the tegmentum and 
interpeduncular nucleus. Pux7 was no longer found expressed in caudal thalamus or 
in a line of expression from mesencephalic flexure to the fourth ventricle. The caudal 
high, rostral low gradient across the dorsal layers of the superior colliculus and the 
dorsal high, ventral low gradient across the superior colliculus continued in the 
mature brain. Pax7 expression was also found ventral to the laterodorsal tegmentum 
(Fig. 4.6B) and in the rostral part of the lateral interpeduncular nucleus. In sections 
further from the midsaggital cut, Pax7 expression became limited to the superior 
colliculus. 
Sci was found evenly expressed across the superficial grey layers of the superior 
colliculus in a high density (Fig. 4.6Al, A2). A gradient of decreasing density was 
observed from dorsal to ventral in the superior colliculus. Sci was expressed 
throughout cortical regions of the inferior colliculus. Outside the superior colliculus, 
Sci expression extended in more lateral sections than that of Pax7, mainly in the 
inferior colliculus and ventral midbrain region. In pretectum, Sci expression extended 
to the precommissural nucleus and parafascicular thalamic nucleus. In rostral 
hindbrain, Sci was also found expressed in the laterodorsal tegmentum (Fig. 4.68). 
Co-localisation was indicated by light microscopy in the dorsal superior colliculus 
with a high density of co~expressing neurons found in the superficial grey layer (Fig. 
4.6Al, A2). Confocal analysis confirmed that a high population of cells within the 
dorsal superior colliculus did co~express Sci and Pax7 (Fig. 4.6A3). Although it 
would be useful to quantify the degree of co~expression in this area, confocal analysis 
does not allow for this as the laser bleaches the fluorescent signal and the light 
microscopy model carmot accurately enough determine those cells that co~express the 
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two factors. Both factors were also found to be expressed in the lateral 
interpeduncular nucleus. But here co-expression was excluded as Pax7 expression 
was found in the rostral part of the lateral interpeduncular nucleus and Sci found in 
the ventrocaudal part of the lateral interpeduncular nucleus. For analysis at both the 
P21 and adult timepoints, two P21 and two adult mouse brains were utilised for light 
microscopy while one for each timepoint wa!l analysed for fluorescent and confocal 
microscopy. For the P21 timepoint, 180 brain sections were (irnmuno)histochemically 
stained and 234 brain sections were stained and analysed under light microscopy for 
the adult brain analysis. 
In summary, the expression pattern of both Pax7 and Sci each remained relatively 
consistent during the process of development from E 12.5 until adulthood. 
Comparative analysis of the two patterns over time reveals the partial overlap 
particularly in the developing pretectum, tectum and specific rostral hindbrain 
regions. However, the most striking result was that co-expression was only confirmed 
in the mature superior colliculus, specifically in the dorsal visual layers of the 
midbrain structure. 
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5. DISCUSSION 
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5.1 NEW FINDINGS IN TillS STUDY 
The major result from this study was that Pax? and Sci were found to co-localise 
within a subpopulation of postmitotic cells in the mature superior colliculus but with 
no evidence for this during embryogenesis, although co-expression in the pretectum 
before birth cannot be excluded. This contrasting outcome was striking because based 
on the preliminary studies in adult tissue, co-localisation behveen Sci and Paxl 
during brain development bad been anticipated. 
5.2 CHANGE OF FUNCTION OVER TIME FOR PAX7 AND 
SCL 
In contrast to a range of neurogenic transcription factors which cease to be expressed 
after neurogenesis, like ta/2 (Bucher et al., 2000) and mash I (Lo et al., 1991) among 
others, Sci and Paxl continue to be expressed in the adult brain. This unperturbed 
expression over time suggests a possible change in function from playing a crucial 
role in neuronal differentiation before birth (Kawakami et al., 1997) to one of 
maintenance of a fully differentiated cellular phenotype within the dorsal layers of the 
superior colliculus in the adult brain. 
My observation that Sci and Pax? were not found in the same cells during embryonic 
neurogenesis, whereas they were found co~expressed in the same cells of the fully 
developed brain is likely to support this proposed change in function of Pax? and Sci 
over time. A described molecular mechanism which would allow a change of 
function of transcription factor Sci over time and/or in different cells based on the 
finding that Scl acts as a gene regulatory protein within a multiprotein complex. 
Depending on the nuclear protein partners within such a complex, Sci is known to 
influence the expression of different downstream genes in different cell types (Begley 
and Green, 1999; Lecuyer and Hoang, 2004). Although less is known about the 
molecular mechanism of action of Pax7 at the level of the DNA, a similar principle 
cannot be excluded. Thus, combinations of specifically co~expressed transcription 
proteins form multifactorial complexes that transcriptionally regulate other proteins. 
Expression changes of these factors may alter the target or the function of a complex 
and the loss of one factor may prevent the complex from forming (Lecuyer and 
Hoang, 2004). Such a disruption of a gene regulatory event during brain development 
may have consequences for the cascade of these events, which underlie proper 
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development of the central nervous system (Anderson, 1997). In this study, it may be 
that in the cascade of events defining embryonic neurogenesis in the tectwn, Sci is 
downstream of Pax?, as Pax? expression is evident in the majority of proliferating 
neural stem cells in the ventricular zone of the aqueduct, where no Sci has been 
detected so far (this study; van Eekelen et al., 2003). If so, the absence of postmitotic 
embryonic tectal cells expressing both Sci and Pax? may then imply that Sci 
expression is permitted only if the Pax? expression is downregulated after 
proliferation. Alternatively, those cells that remain positive for Paxl and have been 
observed migrating from the ventricular zone to the dorsal tectallayers do not allow 
the expression of Sci. On the other hand, expression of different isofonns or splicing 
variants of Paxl and Sci would allow different functioning in different cells and 
tissues. A series ofisofonns for both Paxl (Ziman et al., 2001a) and Sci (Calkhoven 
et al., 2002) have been reported but it is not known which isoform is present at what 
timepoint or in what region. Finally, the presence of a specific DNA binding 
sequence for Sci, the E-box in the Paxl gene suggests the theoretical feasibility that 
Sci could regulate the expression of Paxl (Nielsen, 1996; Begley and Green, 1999; 
Lecuyer and Hoang, 2004). Although this study does not provide the evidence for any 
of these mechanisms of action to happen, the possibility of a change in function over 
time is strongly implied by my observed alteration from expression of Pax? and Sci 
in different embryonic neurons to co-expression after maturation of the brain. 
In recent times it has been suggested that neurogenesis is taking place within the adult 
brain. This is generally accepted to be occ\Jrring in the dentate gyrus and the 
subventricular zone (Arvidsson et al., 2002; Fabel et al., 2003; Jin et al., 2003; 
Montaron et al., 2003; Perez-Martinet al., 2003; Yoshimura et al., 2003). Other 
studies have explored alternate regions for evidence of adult neurogenesis (Lie eta!., 
2002; Zhao e! al., 2003) with the latter finding progenitor cells in the substantia nigra 
suggesting that o. basal replacement of neurons is taking place. Although the role of 
Paxl during emt..!'!'onic neurogenesis involves the proliferation and early 
specification of neural 5:em cells, it seems unlikely that in the adult brain with Pax? 
expression observed in such a large number of scattered cells in the superior 
colliculus, these cells would indeed be neural stem cells undergoing continual 
regeneration. With the close proximity of the dentate gyrus to the superior colliculus, 
in histochemically analysed sections, studies based on the analysis of BrdU 
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incorporation into dividing cells being either neural stem cells or progenitor cells in 
the CNS (Arvidsson eta!., 2002; Hellston, 2002; Fabel eta!., 2003; Jin eta!., 2003; 
Yoshimura et al., 2003) should have identified a high population of ceHs turning over 
within the superior colliculus ifneurogenesis were occurring to such an extent. 
Co-localisation of neural marker NeuN in every Sci expressing cell in adult brain 
indicates that Sci is expressed in neurons (van Eekelen et al., 2003). With 
confinnation of the co-localisation of Sci and Pax7 in the dorsal superior colliculus, 
this would indicate indirect but convincing evidence that in co-localised cells, Pax7 is 
also expressed in neurons. This has not previously been determined as both Pax? and 
NeuN antibodies are raised in the same species (mouse) and cannot be differentiated 
by the anti-mouse secondary antibody used in immunohistochemical analysis. If we 
are to believe that NeuN is indeed a mature neuronal marker, then the expression of 
Pax7 in mature ~eurons is also further indication that it is unlikely that Pax7 
expressing cells in mature superior colliculus contribute to adult neurogenesis. 
5,3 DYNAMIC EMBRYONIC EXPRESSION PATTERNS OF 
PAX7 ANDSCL 
Infonnation derived from knockout studies (Mansouri et al., 1996; Bradley et al., to 
be submitted) has shown that both Pax7 and Sci are important neurogenic factors. 
Surprisingly in the embryonic tectum and developing superior colliculus there is no 
co-localisation found between the two factors. From E15.5, Pax7 is expressed in the 
dorsal ventricular zone in nearly every cell. Here stained cells are seen migrating to 
the developing tectum. Pax7 expression may be involved in the proliferation and 
early specification of newborn cells and in the persistence of the ventricular zone at 
this stage. At PO and P5, extensive Pax7 expression is seen across the superior 
colliculus with high density staining in the dorsal layers coinciding with a time of 
considerable radial growth and the removal of fibre bundles from the superficial grey 
layer of the superior colliculus. Sci expression on the other hand is found in the 
intennediate and marginal zone of the tectum and tegmentwn at E12.5 neighbouring 
the ventricular zone. By E 15.5 and E 18.5, the Sci expression pattern is confined to the 
most dorsal layer of the superior colliculus. This highly specific and non-overlapping 
expression pattern of Pax7 and Sci may suggest that Sci and Pax7 have similar roles 
in neuronal subtype sp~cification in the presumptive superior colliculus/tectum. 
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However, they do not seem to exert this similar function in the same cells. It is likely 
that Sci and Pax? are involved in the neuronal differentiation of different 
subpopulations of neurons during tecta! development. 
Pax? has been described as a detenninant in the mid/forebrain boundacy fonnation in 
the embryonic brain (Kawakami et at., 1997; Nomura et al., 1998) where it is 
involved in a mutually repressive role with Pax6. The region of overlap between 
Pax6 and Pax7 (Stoykova and Gruss, 1994) is found in the posterior commissure. Scl 
is also found in the posterior commissure possibly co-expressing with Pax? although 
confirmation was technically not possible (discussed later in this discussion). If there 
is co-localisation between Pax7 and Sc/ then this may imply that both factors are 
involved in boundary formation between the thalamus and midbrain. 
Similar overlap of Sci and Pax7 expression was seen in the isthmus or wider 
mid/hindbrain region stretching from the mesencephalic flexure to tegmental and 
rostral hindbrain regions bordering the fourth ventricle. Interestingly, in this 
organising region Pax? is found expressed in rostral hindbrain and not midbrain. This 
is surprising as Pax7 is described as a factor involved in the delineation, polarisation 
and regionalisation of the midbrain (Jostes et al., 1990; Stoykova and Gruss, 1994; 
Kawakami et a!., 1997). With the lack of a detailed Pax7 map this might have raised 
expectations in the past that Pax7 would be found expressed on the midbrain side of 
the boundary. 
5.4 GENERATION OF AN EXPRESSION MAP FOR P AX7 
To investigate the potential co-expression of Pax7 and Sci, a detailed mouse brain 
map was required and generated for Pax7 in the absence of an established expression 
map at different embryonic timepoints and in the postnatal mouse brain Previous 
Pax? expression patterns have been described at the E13.5 timepoint and in adult 
brain (Stoykova and Gruss, -1994) but the unavailability of a map at other crucial 
timepoints during brain development hampered accurate expression description of 
Pax7. The maps at E12.5, 15.5, 18.5, PO, PS and P21 that were generated in this 
project allow the Pax7 expression pattern to be followed during brain development 
and the early postnatal brain. Generally, the Pax7 positive regions stayed the same 
throughout brain development although with varying densities of Pax7 expressing 
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cells and/or varying intensities of Pax? at the different timepoints mentioned. The 
mapping at the P21 timepoint revealed the adolescent brain to be comparable to that 
of the adult brain both in terms of Pax? expression pattern and anatomical features. 
5.5 APPLICATION OF GENETICALLY MANIPULATED 
REPORTER MICE FOR SCL EXPRESSION 
In the past monoclonal as well as polyclonal antiserum against Sci have been raised in 
the group of Prof. Begley. Unfortunately, the use of these antisera proved limited in 
immunohistochemistry. Only Smith et al, 2002 has reported successful 
immunodetection of Sci in the embryonic spinal cord. It is thought that expression of 
different Sci isoforms in different tissue or brain regions may not recognise or be 
accessible to the antisera, explaining the failure of these antibodies in 
immunohistochemistry. To alleviate this problem of Sci detection in brain sections, 
van Eekelen et a!. ('03) have previously used the Scl LacZ knockin reporter mouse. 
Newly generated transgenic mice expressing CreER(T) under the 0.9E3 neural 
enhancer of Scl crossed to R26R reporter mice can also be used and this has been 
described in detail in the introduction of this thesis. Unexpectedly, the 0.9E3 
CreER(T) x R26RweYfp model presented some difficulties in this study. At some 
embryonic timepoints the eY.fP signal did not reach the required detection threshold to 
be able to confirm cowlocalisation with Pax? fluorescent staining using confocal 
microscopy. This may be because the time allowed for e Yfp production after the 
tamoxifen injections was not long enough to generate sufficient eYfp protein to 
autofluoresce a strong enough signal. Alternatively, some interference while crossing 
the placenta may have reduced the amounts of available tamoxifen to the embryo to 
reduce the gene recombination of the R26R locus to express eYfp. Further, as the 
eYfp autofluoresces and no antibody to eYfp is avajlable, it is not possible to amplify 
the signal as can be done when an immunofluorescent detection method is applied. 
In summary, I have conducted a comparative expression analysis of two neurogenic 
factors from different transcription factor families, of which expression of both is 
sustained after birth in overlapping brain regions. These factors co-localise in the 
same neurons of the superior colliculus but only after maturation of the brain. During 
the process of brain development these two factors could have similar functions in 
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neural differentiation but in segregated cascades of gene regulatory events for 
different postmitotic neural progenitor populations. 
5.6 FUTURE RESEARCH 
Proposed short-term experimental research, 
-To add complexity to this study, mapping the coronal sections of the mouse brain at 
each timepoint wia allow a thorough three-dimensional analysis of the co-expression 
patterns of Pax7 and Sci. 
- To differentiate the layers of the superior colliculus particularly at those ages where 
no specific map is available, gold myelin and acetyl cholinesterase stainings could be 
carried out in adjacent sections. This is ideal to delineate the layers of the superior 
colliculus and will allow better interpretation of the results on a cellular expression 
basis. 
- To ascertain whether the high expression of Pax7 in the dorsal superior colliculus at 
PO and P5 is from migrating cells into the superior colliculus, which enhance the total 
number of Pax7 expressing cells or an increased or newly induced expression within 
existing cells of the dorsal layers, cell counting could be performed at El8.5 and PO. 
Conversely, cell counting could determine whether the decreased density of staining 
in the adult brain resulted from a downregulation of Pax 7 or an expansion of the 
superior colliculus. This could be achieved by co-staining with Nissl and expression 
of Pax7+ cells as a percentage of total cell counts. 
- To determine overlapping and abutting expression patterns of Pax7 and other 
described neurogenic factors contributing to the patterning of the embryonic brain to 
study their involvement in the developmental cascades at the mid/forebrain and 
mid/hindbrain boundaries. Co-staining experiments based on the use of different 
antibodies against these factors involved at the boundary regions during embryonic 
neurogenesis could be performed. 
Proposed longer term experimental research, 
To identify and quantify alterations of the expression patterns of Sci and Pax7 
in the adult brain, lesion studies could be investigated. The studies based on the 
destruction or deafferentation of specific brain regions may well verify whether Pa'C7 
plays a role in the repair and maintenance of the midbrain after lesioning the retina-
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tectal connection thereby causing injury in need of a repair or regeneration process in 
the superior collicuius itself. 
To determine if different Sci isoforms exist within the brain, biochemical 
analysis using Western blots could be perfonned. 
Finally, to investigate whether Sci and Pax7 associate with each other or with 
other factors in the same multiprotein complexes regulating gene expression 
irnmunoprecipitation experiments could be conducted. To study whether Pax7 and 
Sci regulate downstream genes or each other's expression can be addressed by 
microarray analysis of cells in which both Pax7 and Sci are expressed. 
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